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EXECUTIVE SUMMARY
This annual report covers the activities of the New England Genetics Collaborative (NEGC) from June 1,
2010 to May 31, 2011. The purpose of this report is to provide the reader with additional documentation on
the utilization of grant funds and what has been achieved as a result, to provide an overview of NEGC
activities for both old and new partners, and to offer recommendations for the collaborative's improvement
and ultimate achievement of its mission and vision.
Mission: The mission of the NEGC is to promote and improve the health and social well-being of those with inherited
conditions through collaborations among public health professionals, private health
professionals, educators, consumers and advocates in Maine (ME), New Hampshire (NH), Vermont
(VT), Massachusetts (MA), Rhode Island (RI) and Connecticut (CT).
Vision: All individuals with genetic conditions living in New England have the opportunity to achieve their fullest
potential.
This report includes: a summary of activities by the Regional Coordinating Council (RCC), Workgroups, and
Evaluation Staff during the period; primary findings of the project’s fourth stakeholder survey; an update on
the status of core project components from Year Four; a list of objectives for each group for Year Five; and
recommendations to the project by the project evaluator. The material provided in this report is based on
information submitted to evaluation staff as of Oct. 1, 2011. Members of the Collaborative Council were
provided an opportunity to review and comment on the enclosed material. Evaluation of the project is led by
Peter Antal, Ph.D., Institute on Disability, UNH.
The current New England Regional Genetics and Newborn Screening Collaborative (NEGC) grant (HRSA
Grant # U22MC10980) officially began June 1, 2007. During its fourth year of activity, core project staff have
continued to focus on improving the infrastructure of the NEGC (launching the new website, improving the
RFP process, and structural improvements to the organization) and increasing support to coalition members.
Together with the Workgroups, they have been meeting and carrying out the work of the NEGC through a
broad range of collaborative activities, including a special focus on metabolic centers workforce capacity and
launching New England's first Emergency Preparedness symposium. The Quality Improvement Workgroup
completed business associate agreements with centers in Maine and New Hampshire with Vermont’s in
process to support quality improvement activities and successfully launched a new learning collaborative with
8 participating metabolic centers representing all NE states. The Transition Workgroup continued to build on
both regional and national level activities, implementation of a new Teen Challenge Program, disseminating
the Transition Toolkit, and collaborating with national partners. The Medical Home Workgroup pursued the
development of a new survey needs assessment to document care, coordination and communication practices
among primary care providers, specialists and families. The Dissemination, Education, and Marketing
Workgroup developed the framework and background material for the new GEMSS website for special
educators to improve support for students with genetic conditions. The Laboratory Quality Assurance
Workgroup conducted analyses and compared results to follow-up for: 3MCC, BKT, GA-I, MSUD, CIT-I,
and ASA, with a presentation to the Laboratory Subcommittee of the SACHDNC. Lastly, the Long-Term
Follow-up Workgroup achieved a major accomplishment by solidifying an agreement with legal
1

representatives from Rhode Island which allows for the collection of LTFU data. Additionally, they held a
national conference on improvement of long-term outcomes for individuals with Sickle Cell Disease.
Concerning stakeholder satisfaction with the progress of the NEGC, findings from the recently completed
stakeholder survey showed multiple improvements over the previous year. A majority of respondents (N=63)
understood the mission of the NEGC (73%) and felt that the NEGC has made clear and substantive progress
in achieving its mission (72%). In reviewing the goals and objectives for Year Four, 96% of 54 objectives
have either been completed (63%) or have made satisfactory progress (33%) in accordance with the long term
goals of the grant. Objectives for Year Five have been shared and agreed to by project staff and chairs of the
project’s work groups. In preparing to successfully meet the collaborative's objectives, a range of challenges
and recommendations for improvement have been identified in the final section of this report.
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COALITION CHANGES AND IMPROVEMENTS
Organizational Overview
The Regional Coordinating Center (RCC) is staffed by John Moeschler, MD and Monica McClain, Ph.D.,
who serve as Principle Investigators, Ms. Karen Smith as Project Coordinator, Kit McCormick as Project
Staff, and Peter Antal, Ph.D. as Project Evaluator. Administrative support is provided by the UNH Institute
on Disability, which acts as fiscal agent.
In 2010 – 2011, the RCC carried out substantial portions of its work through six Workgroups: Quality
Improvement, Medical Home, Transition, Laboratory Quality Assurance, Long Term Follow-Up, and
Dissemination, Education and Marketing. The chair of each Workgroup is a member of the Collaborative
Council; the Council meets three times a year to facilitate coordination of Workgroup activities. The RCC and
Collaborative Council are guided by an Advisory Committee which meets annually to help set direction for
the collaborative and to provide feedback / raise issues throughout the year as needed. Lastly, a Review
Committee is formed annually to provide review and guidance on funding requests from the collaborative's
innovative projects program. Please see Appendix A for the current organizational chart.

Organizational Improvements
During Year 4, the NEGC staff focused on strengthening its communication strategies and supporting
sustainability efforts for genetic services region wide.
Implementing the Communication Plan
During the course of the project year, project staff launched a new e-newsletter describing NEGC activities
and important updates for partners and made a range of enhancements to the project's website
(www.negenetics.org). Enhancements were made in the following areas:
•

•

•

Structural
o New site launched in December, 2010
o Expanded list format for presenting information
o Improved access to information for families and professionals
o Added join our mailing list option, twitter link
o Improved access to products and publications
o Enabled password protection for joint team review of grant applications for innovative
projects
Information
o Added more state resource information
o Provided updates to Did You Know and Featured Resource allowing for easier highlighting of
key activities
o Extracted glossary of terms and made accessible on website
Design
o Updated graphics throughout to reflect diversity
o Redesigned logo
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NEGC Visitors

Total Count

Between November 2010 and May 2011, there were 962 unique visitors to the NEGC website and 2,349
visits. Over the course of these 7 months, the number of users and visits gradually increased, the average time
spent on the website increased from 3:52 to 5:31 minutes, and the average number of page views increased
from 2.4 to 6.0, with total page views increasing from 258 to 2,758.1
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Fig. 1 NEGC Unique Users and Visits
Nov. 2010 Through May 2011
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As the NEGC grows it will be helpful to track how the NEGC is doing relative to its outreach efforts and to
identify what kinds of outreach works best. In looking across different referral sources to the website and the
levels of activity generated (See Table 1), the most effective source was direct web links provided to
stakeholders, with 77 visits generated and an average time of 6:58 minutes per visit, followed by referrals from
partner organizations which generated 337 visits and an average time of 4:23 minutes. Of note, links driven by
social media (Tumblr, Facebook, Twitter) accounted for 200 visits, an average time of 0:55 minutes on the
website and a bounce rate of 89%. Other refers primarily to web market generated referrals from PRweb.com
and other unaffiliated sites.

1

The reader should note that these numbers are lower than previous years due to the fact that a completely different
tracking system was used in conjunction with the new website. The new program, run through Google Analytics, provides a
more accurate and detailed view of NEGC website users. Given the substantive changes, the numbers presented this year are
not comparable with data from the previous year.
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Sources of Referral to the NEGC Website
Table 1: Referring Sources to the NEGC Website
Source
Direct Link

Visits
Pages/Visit
777
6.6

Avg
Time
0:06:58

% New
28.7%

Bounce
Rate2
36.4%

Partner Org

337

4.6

0:04:23

35.0%

38.9%

Email Referral

23

4.2

0:01:41

47.8%

52.2%

Search

871

2.7

0:01:40

66.1%

55.5%

Social

200

1.6

0:00:55

2.5%

89.0%

Other

54

1.6

0:01:25

3.7%

50.0%

Outside of the IOD, the top five organizational drivers to the NEGC website was the NCC (88), NBS
Clearinghouse (22), MCH LEND (21), CDC (19), and the New England Consortium of Metabolic
Programs(11). A total of 21 organizations were identified as referral sources to the NEGC.
National Outreach of the NEGC
Of the 2,165 visitors to the NEGC website, about half were from New Hampshire (995)3. States with 50 or
more visitors include: Massachusetts (277), Georgia (96), Connecticut (96), Vermont (88), New York (61),
Maine (60), and California (51); please see Fig.1.

2

Bounce rate refers to percentage of initial visitors to a site who "bounce" away to a different site, rather than continue on to
other pages within the same site
3
However, 604 visits (61%) of the NH traffic were generated from the city of Durham (where the administrative staff of the
NEGC resides).
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Figure 1: Distribution of NEGC Website Traffic by State

Resource Leveraging
During Year Four, NEGC staff submitted one grant application to support new or expanded work in genetics
in the New England region. This application was not funded. The NEGC provided 5 letters of support for
five projects, two of which were funded.
Table 2: Applications and Letters of Support
Direct Applications
Grant Name
Natural History of Disorders
Identifiable by NBS

Description
Project Yr 4. NIH.

Amount
NOT FUNDED

Letters of Support for Partner Applications
Grant Name

Description

Genetics in Primary Care Institute

Project Yr 4. American Academy
of Pediatrics. Create a community
of learners to enhance primary
care provider ability to provide
genetic related services, address

Amount
Funded.
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systems and policy supports to
accelerate provision of genetic
medicine, assess residency training
curriculum for genetic medicine.
Family to Family Health
Information Center

Project Year 4. Federation for
Children with Special Needs.

Funded.

NBSTRN

Project Year 4. American College
of Medical Genetics. Build an
electronic data capture tool for
long term follow up of children
identified by newborn screening.

Letter written to support need for
this activity.

Noonan Foundation

Project Year 4. Children’s Hospital Not funded.
Boston. For follow up meetings of
the Face Forward Program.

The Parent-Child Relationship and
Newborn Screening: Preserving
the Ties that Bind

Project Year 4. Assess whether the
parent-child relationship is
disrupted in parents whose infant
receives an initial out-of-range
newborn metabolic screening
result and whether uncertainty
surrounding the result is
associated with reduced selfreported ratings of bonding for
both mothers and fathers.

Not funded.

For a complete list of resources leveraged to date, please see Appendix B.
New Committee Launched - Advocacy Committee
As a result of feedback gathered from the 2010 Annual Meeting, the NEGC brought together 13 individuals
representing all New England states, as well as a range of professional and family interests. The group
brainstormed a range of project ideas with the result of focusing directly on the concept of essential benefits
under health care reform. Through a partnership with NH Family Voices, an application was developed and
submitted to the NEGC Innovative Projects program. Although the effort was not funded, the group
anticipates continuing to work on this area during Year 5 of the project as well as providing feedback to the
NEGC on how it can best meet the needs of individuals and families.

Collaborative Activities
Project staff continued to seek out new opportunities for partnerships with both regional and national
partners. During Year Four, this included: joint planning of the annual meeting with NERGG, 11
presentations and 5 publications by affiliated staff, 10 training/technical assistance activities, 4 newly funded
innovative projects, 3 applications supported through the community and family network grants, special
7

projects supporting the mission of the NEGC, and continuing collaborations with regional and national
partners. The following outlines each of these accomplishments in more detail.
Annual Meeting, Dec. 1, 2010
The annual meeting was well attended by 65 partners in the initiative, representing an increase of 19
participants over the previous year. Project staff highlighted the key accomplishments of the project over the
course of the past year and identified major activities to be undertaken for next year. Breakout sessions on
how to effectively engage with genetic counselors, families, and the New England Birth Defects Consortium
were held. In addition, open workgroup meetings were held that enabled cross group and new stakeholder
participation in the activities of individual workgroups.
Most participants found the meeting helpful, that they had opportunities to share their perspectives, that they
had a good understanding of what the NEGC will accomplish in Year 5, and that the NEGC is “headed in
the right direction.” More than half of responding participants felt that the work of the NEGC resulted in
tangible outcomes resulting in improvements in high quality genetic services in the region. In terms of
recommendations, participants highlighted a range of groups to which the NEGC staff could do additional
outreach, including major medical centers, school nurses, family advocate groups, March of Dimes, Save our
Babies, Medicaid leadership and other major organizations (AAP, AFP, ACM, CCPCMH). A copy of the full
meeting 'mid-year' report is available at http://www.negenetics.org/AboutUs/Evaluation_reports.aspx.
Presentations and Publications Supported by the NEGC
During Project Year Four, NEGC coalition stakeholders conducted 12 presentations about project activities.
This included an update on Long Term Follow Up (LTFU) activities in New England to the National
Coordinating Center / Regional Center Annual Meeting as well as a short course on CF NBS and Care
Quality Improvement at the the 2010 North American Cystic Fibrosis Conference. Both sessions were
conducted by Dr. Anne Comeau. A third presentation was by Dr. Susan Waisbren during a conference on
neurocognitive issues in PKU and transition to adult care. For a detailed listing of presentations and
presenters to date, please see Appendix C.
By the end of Project Year Four, 5 additional publications were created by NEGC collaborative council
members, bringing the total publications list of NEGC stakeholders up to 204. The most recent publications
include:
 McGrath RJ, Stransky ML, Cooley WC, Moeschler JB. National profile of children with Down Syndrome:
disease burden, access to care, and family impact. J Pediatr. 2011; in press.
 Woo HC, Lizarda A, Tucker R, Mitchell ML, Vohr B, Oh W, Phornphutkul C. Congenital hypothyroidism
with a delayed thyroid-stimulating hormone elevation in very premature infants: incidence and growth and developmental
outcomes. J Pediatr. 2011;158(4):538-42.
 Sahai I, Eaton RB, Hale JE, Mulcahy EA, Comeau AM. Long-term follow-up to ensure quality care of
individuals diagnosed with newborn screening conditions: early experience in New England. Genet Med. 2010;12(12
Suppl):S220-7.
4

The number of total publications has been reduced from last year due to updated definitions from national partners as to
what constitutes an NEGC supported publication.
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 Hale JE, Parad RB, Dorkin HL, Gerstie R, Lapey A, O'Sullivan BP, Spencer T, Yee W, Comeau AM.
Cystic fibrosis newborn screening: using experience to optimize the screening algorithm. J Inherit Metab Dis.
2010;33(Suppl 2):S255-61.
 Fanos JH, Wiener L, Brennan T. Potential impact of genomic information on childhood sibling relationships. In:
Handbook of genomics and the family, Issues in clinical child psychology, K.P. Tercyak (ed.), Springer
Science, 141-61, 2010.
For a detailed listing of publications supported by the collaborative and its members, please see Appendix D.
Trainings and Technical Assistance
Through its many collaborators and supporters, staff funded by the NEGC carried out a range of training and
technical assistance activities to families, consumers of health services, health providers, education providers,
state staff, community organizations, and others. Of the 3,309 aided in this manner, an estimated 3,000
individual contacts were made by the Birth Defects Consortium in its effort to improve understanding and
utilization of folic acid during pregnancy. Additional areas of focus touched on: support around Down
syndrome education, emergency preparedness, support for grant applications and conducting research,
training professionals on assessment tools and transition practices, training staff on the use of learning
collaboratives, database utilization for improving care, and the legal aspects of data use.
Innovative Projects
The RCC continued to build on the innovative projects program and completed its fourth round of grant
funding. The NEGC received 10 proposals and awarded four grants, with a combined total disbursement of
$86,985. The studies funded by these grants include:
•

"Exploring and identifying the knowledge level and attitudes of (selected) diverse
populations toward genetics and genetic services," submitted by Patricia Rissmiller of Simmons
College. Awarded: $12,500.
Four focus groups were held to gain an understanding of how select diverse populations think about
and discuss genetics and genetic services. One focus group involved 15 members of the Haitian
Community Group and three groups were held at the Somalian development center, with 7-10
women participating in each group. Initial review indicates that, although participants had limited if
any knowledge of the topic, they were eager to learn more. Next steps for this effort are to complete
the analysis of the focus groups and to consult with the organizations to identify the most culturally
relevant strategy to educate the community about genetics and genetic services. If successful, a long
term goal will be to launch this effort on a broader scale via a community based participatory research
grant.

•

"Implementation of the New England Birth Defects Consortium - Year 2", submitted by
Stephanie Miller of Dartmouth Medical School. Awarded: $30,000.
In addition to formalizing the Consortium via regular meetings and membership development, the
Consortium collaborated with the Women, Infants, and Children departments in each of the six New
England states to launch a multi-vitamin distribution campaign. As a part of this effort, the
Consortium is conducting a pre and post survey study (ending 12/31/11) that will document the
utility of a multi-vitamin distribution campaign to improve knowledge of folic acid use among
9

women. A second major effort of the group this year focused on determining the utility of combining
data for 12 birth defects across participating states. Data for this effort was collected from Maine,
Connecticut, Rhode Island and New Hampshire, with Vermont sending data in 2011. The NEBDC
notes that it had a successful second year and plans to work together and maintain the integrity of the
group in the future. It looks forward to working with the NEGC on future activities as needed.
•

"Integrative Community-Based Management for Adults with Sickle Cell Disease," submitted
by Victoria Odesina of UConn Health Center. Awarded: $15,000.
Two home care agencies (Masonicare Partners Home Health & Hospice and the VNA of SouthCentral Connecticut) were successfully recruited and became active participants in a multi-agency
effort to provide integrated community based care for adults with sickle cell. Participants received
educational information on integrative care models, clinical research ethics, and participatory research.
During this first year of the project, partners identified a list of home health care needs for adults with
SCD. Additionally, home care agencies received information on the services that would and would
not be covered by insurance companies as well as the fees for other services that may be needed but
not covered for this population. The group created an MOU and outlined a series of objectives for
project year two which outlines the working relationship among partner organizations including their
roles and responsibilities as part of their involvement in the Collaboration of Care for Adults Living
with Sickle Cell Disease. The overall goal of the collaboration will be to improve the home health care
and quality of life for adults with SCD with a specific focus on: appraising home services needs of
adults with SCD, facilitating home care management prescriptions for clients and providers,
demonstrating a seamless sharing of client health information concerning acute, chronic care and
coordination needs, maintaining or increasing community social supports and providing prevention
and health education services for improving functional status and health related quality of life
indicators, and examining the cost effectiveness of home health care on ER visits, day treatment or
inpatient care.

•

"Increasing Access to Care for Newborn-Screened Children with Fatty Acid Oxidation
Disorders," submitted by Dr. Susan Waisbren of Children's Hospital, Boston. Awarded: $29,485.
Dr. Waisbren focused on improving access to psychological and developmental evaluations for
patients with fatty acid oxidation disorders (FAODs) and to improve education about the
developmental and psychological issues in FAODs.
The project identified 41 patients with FAODs and focused on conducting 21 interviews with parents
of children with MCADD. In addition to in-person interviews, parents completed questionnaires
assessing overall functioning, emotional well being, and executive functioning. Four families of older
children were contacted to assess school outcomes and medical records were reviewed on an
additional 20 children with other FAODs to examine results from the parent questionnaires and
developmental and neuropsychological testing.
Of note, the study's results suggest that children with FAODs may have emotional and learning issues
that have not previously been recognized by assessments such as the Bayley Scales of Infant
Development or tests of intelligence. Forty-four percent of children in the study had scores in the atrisk range on withdrawal scales and 33% had scores in the at-risk range on anxiety scales from the
Behavioral Assessment System for Children. The potential implications of these factors were
discussed particularly as they related to energy depletion and school and the decreased likelihood of
10

youth seeking out and obtaining needed nutrients throughout the day. It was also noted that teachers
may not be aware of the disorder or understand the symptoms that children may experience.
In response to these findings, the project developed the MCADD Educator's Guide to help teachers
better understand the disorder and prevent problems related to an FAOD from occurring. The Guide
will be posted online at: http://newenglandconsortium.org and at www.negenetics.org. In addition,
the guide will be featured on the GEMSS website, developed by the DEM workgroup, upon its
completion.
For final reports submitted by each of the above grant recipients, please visit the NEGC website at:
http://www.negenetics.org/innovative.html.
Community and Family Network (CFN) Grants
During 2010, community and family level innovation and participation in genetic services was supported by
three CFN grants. Five applications were submitted and three were approved. The awardees include:
•
•

•

National Tay-Sachs & Allied Diseases Association (NTSAD). $2,500 was provided to support the
development of a new web site (www.ntsad.org), increasing access to comprehensive information for
families & members, which would in turn increase donations and support for the organization.
Maine Down Syndrome Network: $2,500 was provided to help cover costs of presenters at their
annual conference in November 2010. Presenters included: Susan Shapiro (“Friendship for all Kids:
What to Do and What to Undo”), D. Kelley Young (“Estate Planning: Thoughts and Concerns for
Parents”), and Dr. David Stein (“Behavioral Problems and Behavioral Interventions In Children with
Down Syndrome”).
Alzheimer’s Association, CT Chapter: $2,460 provided to support the keynote speaker (Dr. Robert
Green) on the genetics of Alzheimer’s Disease, at their annual conference in November 2010.

Special Projects
Throughout the year, the NEGC engaged in several unique projects to improve the field of genetics
education and services. During Year Four, the NEGC supported work in the following areas: assessing
genetic workforce capacity, reviewing emergency preparedness protocols in New England, and clarifying state
rules for information use around newborn screening.
Assessing Genetic Workforce Capacity
Led by Robert McGrath, Ph.D. from UNH and in partnership with the American College of Medical
Genetics, this project reviewed the newborn screening process in five New England states and held a series of
key informant interviews to document care processes for selected patients. Much of the focus of this work
was on understanding the complexities that can hinder the care process as well as the strategies adopted to
address these barriers. As a result, the project documented that the newborn screening processes, while
different for each state, appeared to work well. In taking a close look at the care process following newborn
screening, the authors highlighted three important theme areas worthy of further consideration: 1)
reimbursement for genetic services was found to be particularly burdensome and often lacking; 2) there
continues to be a need for improved care coordination - the authors suggest that new models should be
11

explored which incorporate different roles and approaches among team members/care providers; and 3) the
need for more coordinated approaches to education - not just on how to provide effective educational
resources to families, but also how to ensure that all components of a care team are knowledgeable of the
different roles and needs of each element of the care process. Overall, the study raises the concern that the
field is ill equipped to accommodate future growth in NBS conditions, particularly given potential shortages
in supply of genetic providers. They argue for considering a shift in approach that takes into account where
the whole health system is moving and how best to incorporate this information within a flexible dynamic of
care provision (e.g. rethinking how care teams are structured, how medical homes and care coordination
function for rare conditions).
Emergency Preparedness in New England
On April 1, 2011, Dr. Roger Eaton launched New England's first Emergency Preparedness Symposium. The
event included 23 participants, with representatives from NBS community labs, state and federal emergency
preparedness contacts and two consumers. Presenters included Stan Berberich, Hans Andersson, and Bill
Perry. Participants learned about what worked in other states, identified federal resources that would be
helpful, and identified a range of action steps to pursue. Recommended steps to pursue included: create a
regional group to conduct further planning and implementation, identify clear cut protocols, prepare hospitals
for management of serious cases, improve utilization of electronic records/communication, develop
formalized agreements, create a website to facilitate communications, develop a useful checklist for families,
and provide funding to family-to-family health centers to train and strengthen consumer networks.
Use and Disclosure of Genetic and Newborn Screening Information
In October 2010, Michelle Winchester completed her work analyzing the many differences in state
approaches for using and disclosing genetic and newborn screening information for the purposes of
treatment, a registry, and research. The report provides an overview of relevant guiding policies, addresses
state variations in the use and disclosure of PHI for quality improvement, registry or research activities,
documents relevant state laws, and offers a range of considerations for the NEGC to pursue as it seeks to
improve the coordination and use of information for improved care in the region.
Collaborations with Regional and National Partners
This section provides documentation on the affiliations held by NEGC management and collaborative
council members.
Supporting the National Coordinating Center
The NEGC has representatives in each NCC Work Group:
•
•
•
•

Telegenetics Work Group: Rosemarie Smith, MD
Emergency Preparedness: Roger Eaton, Ph.D.
Long Term Follow-Up Workgroup: Anne Comeau, Ph.D.
Evaluation: Peter Antal, Ph.D.
• Publications: Monica McClain, Ph.D.
• National Transition Workgroup: Susan Waisbren, Ph.D.
12

• Medical Home Work Group: Carl Cooley, MD
Collaboration with Other Regional and National Groups
•
•
•
•
•

•
•
•

•

Genetics and Metabolism Psychology Network: Susan Waisbren, Ph.D.
National Coalition for Health Professional Education in Genetics (NCHPEG): Leah Burke, MD
National Newborn Clearinghouse (Genetic Alliance): Leah Burke, MD
National Health Care Transition Center: Susan Waisbren, Ph.D., Carl Cooley, MD
Newborn Screening Translational Research Network
o Clinical Centers Workgroup: John Moeschler, MD, Anne Comeau, Ph.D.
o Bioethics Workgroup: Anne Comeau, Ph.D.
o Laboratories Workgroup: Roger Eaton, Ph.D., Anne Comeau, Ph.D.
o Effective Follow Up Workgroup: Roger Eaton, Ph.D., Anne Comeau, Ph.D.
o Information Technology Workgroup: Monica McClain, Ph.D.
New England Consortium of Metabolic Programs: Susan Waisbren, Ph.D., Leah Burke, MD
Next Step: Susan Waisbren, Ph.D., Carl Cooley, MD
Secretary’s Advisory Committee on Heritable Disorders in Newborns and Children
o LTFU Sub-committee: Carl Cooley, MD, Anne Comeau, Ph.D.
o Health Information Technology Workgroup: Roger Eaton, Ph.D.
o Evidence Review: Anne Comeau, Ph.D.
Vermont Children’s Health Improvement Program (VCHIP): Leah Burke, MD
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WORKGROUP ACTIVITY IN YEAR FOUR
This section provides an overview description of each workgroup's activities during Year Four. Material
presented is drawn from each group's year-end report to the NEGC, with minor edits to improve readability.
For an across-the-board view of major highlights from each group, please see Appendix E. A record of when
groups met during the course of the year is provided in Appendix F.

The Quality Improvement Workgroup
The Quality Improvement (QI) Workgroup has nine members and is led by the NEGC's Principal
Investigator, John Moeschler, MD. They met three times as a full group between September and November,
2010. During the project's fourth year, workgroup members focused their efforts on three major areas: 1)
development of a legal framework that would allow for entry of protected health information into a quality
improvement registry; 2) creation of web-based software that would house and facilitate development of
electronic reports of patients involved in participating clinics; and 3) implementation of a quality
improvement learning collaborative (QILC).
One of the group's first tasks for the year was to establish a legal framework that would enable the utilization
of patient data across sites. While the group initially pursued creation of a Patient Safety Organization,
substantive background research and discussions with partners resulted in the group dropping this effort in
lieu of an approach based on establishing Business Associate Agreements between each participating clinic
and the hosting data site. Currently 2 centers have established BAAs under HIPAA with UNH and Global
Vision Technologies (GVT), with a third center pending. This arrangement allows entry of protected health
information into the quality improvement registry and enables the cross-site sharing of non-identifiable
aggregated information for the express purpose of improving patient healthcare processes and, eventually,
group outcomes.
The second area of work focused on the creation of a web-accessible data-base. GVT developed and
implemented the NEGC quality improvement data-base, and has provided modifications, as requested. Web
access has been provided to seven genetics health care professionals (physicians and genetic counselors) at
two clinical sites. Data for 186 patients have been entered and a first analysis has been accepted by the
American Society of Human Genetics for an abstract presentation at the annual meeting in October 2011.
For the third area of work, project staff implemented the first regional learning collaborative to address
quality of care issues for individuals living with PKU or MCAD5. In addition to a series of planning meetings,
2 full face to face meetings were held and one support webinar was held. The first session of the QILC
focused on: introducing participants to the QILC model and discussing some of its strengths and limitations;
suggested revisions to the PKU and MCAD data collection forms, a review of work flow at each clinic site
and how the introduction of the new data forms shaped clinic activity, as well as a brief discussion of the
5

for more detail on learning collaboratives, please see:
http://www.ihi.org/IHI/Results/WhitePapers/TheBreakthroughSeriesIHIsCollaborativeModelforAchieving
+BreakthroughImprovement.htm
14

patient registry for individuals with developmental delays. The webinar, held in March, offered participants an
opportunity to begin sharing notes on the implementation process, learned more about the quality
improvement registry and discussed possible linkages. Lastly, in April 2011, participants again met face to face
to review some of the collected data and share what was learned. In general, participants agreed that the
forms were fairly easy to implement on an ongoing basis and several reported unexpected benefits as a result
of form implementation. These benefits include:
• helping a clinic to address the multiple issues that they want to address during a patient's visit
• generating information that is important for care by complementing other care protocols
• supporting quality care by having critical information in one spot and having access to this
information over time
• improving standardization of care
• helping to see overlap in clinic tasks and seeing each person's role in the transition process.

The Transition Workgroup
The Transition Workgroup is led by Dr. Susan Waisbren, who is also the leader of the National
Transition Work Group. The group currently has 18 members. The primary role of the regional Transition
Work Group is to improve access to transition resources, implement innovative models for transition
leadership among youth, and to enhance integration of transition practices into the activities of partner
organizations. The group has solidified due to working together over time in a number of ways. In Year Four
they developed strong collaborations with the National Health Care Transition Center (NHCTC) in NH and
Next Step in MA. These innovative partners have been planning their activities and consulting with each
other in the process of creating a community with shared goals. Specifically, NHCTC, led by Dr. Carl Cooley
(Chair of the NEGC Medical Home Work Group), began conducting transition Learning Collaboratives and
launched the Got Transition website. Next Step and Children’s Hospital Boston planned a summer conference
with expanded outreach for young adults (see details about Face Forward below). Bill Kubicek, Executive
Director of Next Step and member of the Transition Work Group, sits on the NHCTC Advisory Board. Ann
Walls and Mallory Cyr, both with NHCTC, joined the Transition Work Group. Ms. Cyr was also a key
facilitator of Face Forward.
Improving Access to Resources
At the end of Year Three, the group had produced the Transition Toolkit, including both one page
educational fact sheets (Metabolic Basics) and the tool itself (Transition Plan). Usage reports at the end of Year
Four were discouraging in that the tool wasn’t used as much as hoped. The Metabolic Basics, however, were
viewed quite often and for longer periods, suggesting real and meaningful benefits. Further, a physician in the
work group shared that he valued the sheets for their portability and regularly advised families to use them.
The group discussed changing the target audience to providers, who could then steer families to the site.
Developing Young Adult Leaders
The Transition work group continued to address the need for leadership training for teens with metabolic and
genetic disorders through Teen Challenge 2010. This three day camp for young people, aged 13-20, was
designed to build confidence, strengthen bonds, challenge comfort zones and develop some of the skills
needed to manage complex health conditions. 2010’s Teen Challenge was held July 7th - 9th with nine young
people in the rural setting of the Friendly Crossways Youth Hostel in Harvard, MA.
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Another area re-examined by the group was how to engage and empower youth and young adults – an
essential ingredient in a successful transition. Working with Next Step and modeling their strategies, the work
group identified functional outcomes (getting a car, going on a date, etc.) rather than health outcomes as meaningful
motivators. Future efforts may focus more on how to subtly help young adults make the link between being
healthy and reaching their other goals.
This focus became the premise for Face Forward Summer Conference for Youth, jointly sponsored
by Children’s Hospital Boston and Next Step. The conference was held at the start of Year Five, with
planning underway during Year Four. Other modifications made to heighten the success include: 1) creating a
youth council to plan the agenda; 2) including young adult facilitators; 3) changing the age range to 16-24; 4)
stretching it to four days, and 5) including participants with other conditions.
Collaborating with Partners
Members of the Transition Workgroup are integrated with the New England Consortium of
Metabolic Programs, regularly touching on transition issues over the course of the year, as well as meeting in
person at their annual meeting in November 2010. They help drive transition activities in the Consortium by
dissemination of information about the Teen Challenge and the tools on the website.
Since December 2009, the Transition Work Group has been holding joint meetings with the Medical
Home Work Group chaired by Dr. Carl Cooley. They met again in person at the NEGC annual meeting in
December 2010. Dr. Waisbren and Dr. Cooley took initiative by bringing in two young adult presenters who
helped participants come to a better understanding of the youth perspective in engaging the health care
system for genetic conditions. They also held a joint conference call in May 2011. Five new members joined
the Transition Work Group in time for this call: a metabolic specialist, a genetic counselor, a parent, a young
adult with a genetic condition, and the project director of the NHCTC. The thrust of the call was a robust
conversation on how to tell if a person has made a successful transition. Dr. Cooley noted that, other than
information from adult providers, it is difficult to find evidence of research regarding transition outcomes;
sharing characteristics of successful transitions may foster resilience in individuals and families.
Dr. Waisbren also continues to co-chair the National Transition Work Group, which was recently
given “Work Group” status by the National Coordinating Center in recognition of their efforts and their
charge. The group holds monthly calls regularly attended by members of the Transition Work Group,
including the NEGC’s Monica McClain and Karen Smith. There are generally over 12 people on the call, with
3 or 4 from New England. The primary role of this group is to provide a forum for sharing current transition
activities across the nation and discussing new directions for the field. Highlights from the discussion during
the past year include a better understanding of the challenges inherent in developing transition programs
(especially with locating adult specialists), the need to engage the youth in planning programs, the value of
including individuals with various conditions as well as separate break-out sessions when developing
programs, and being honest about what doesn’t work (written transition plans posted on a website rather than
introduced by a provider).

Medical Home Workgroup
During Year Four, the Medical Home Workgroup was led by Dr. Carl Cooley. The 16 member group held 2
formal meetings.
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In Year Four, the group was initially poised to further test a communication tool among specialists, families,
and the primary care medical home. This tool, or care plan, had been conceived and developed in previous
years with the help of Dr. Chris Stille, formerly of UMass Memorial, and with support from the NEGC.
The care plan itself was a one page form in a fillable PDF format. The purpose of the form was to aid
communications between the parent and doctor concerning what has been done and what concerns and
requests should be related. Unfortunately, the group concluded at the end of Year Three that although the
tool itself was deemed useful and user–friendly, it still wasn’t being used in practice settings for a number of
reasons. One of those reasons, noted by a specialist, was that much of the information was already contained
in a letter that was routinely sent from her clinic to her patients’ primary physicians. This led Dr. Cooley to
wonder what other communication methods were already in use.
To explore this question, Dr. Cooley collaborated with the UNH Survey Center to develop the Survey of
Primary Care Clinicians Regarding the Care of Children with Rare and/or Complex Conditions. The
goal of this survey was to assess primary care clinicians' comfort, clarity of role, and quality of communication
in the co-management with specialists of children and youth with rare and/or complex chronic conditions.
Dr. Cooley defined rare or complex conditions as those that occur in less than .1% of children (rare) or that
involve two or more body systems (complex) and require on-going medical management of some kind. While
the conditions are individually uncommon, the aggregate of conditions of this type accounts for 5 - 7% of
children and youth and includes children who are the highest users of health care services.
The survey was sent to email lists of the NH Pediatrician Society (275) and NH Academy of Family
Physicians (604). 115 primary care providers responded to the survey. Further analysis of the survey results
will occur in Year Five. Also in Year Five, Dr. Cooley will conduct a targeted survey/interview of genetic and
metabolic clinics in New England, looking at the same essential question from that point of view, and
collaborate with NEGC staff on a national survey of genetic and specialty clinics. Preparation for that work
was completed in Year Four.
Since December 2009, the Medical Home Work Group has been holding joint meetings with the Transition
Work Group chaired by Susan Waisbren, PhD. They met again in person at the NEGC annual meeting in
December 2010. Dr. Cooley and Dr. Waisbren took initiative by bringing in two young adult presenters who
helped participants come to a better understanding of the youth perspective in engaging the health care
system for genetic conditions.
The two work groups also held a joint conference call in May 2011. Dr. Cooley provided an update on the
National Health Care Transition Center (NHCTC), a separate MCHB/HRSA-funded project he has been
leading since July 2010. He also updated the group on a clinical report, Supporting the Health Care Transition
From Adolescence to Adulthood in the Medical Home. This report, published in Pediatrics in July, 2011, was prepared
by the AAP, ACFP and ACP and Dr. Cooley was a lead author. One major component of the NHCTC has
been to conduct Learning Collaboratives on transition, using to some extent the algorithm for a smooth
transition outlined in the new clinical report.
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Dr. Cooley was selected to chair the National Coordinating Center’s (NCC) Medical Home Work Group.
This committee met in person in January 2011 in Year Four and held monthly conference calls. The primary
role of this group is to develop a common set of definitions and principles across all seven regional genetics
collaboratives related to the medical home and the coordination of care among specialists, primary care
physicians, and families. Highlights of the discussion during the past year include arriving at a common
understanding of medical home, considering models of care coordination and communications between
specialists and primary care, and acknowledging the crucial role of families in the process. The workgroup
intends to produce a white paper related to its deliberations.

Dissemination, Education, and Marketing Workgroup
Leah Burke, MD, chairs the Dissemination, Education and Marketing (DEM) Work Group, which currently
has 12 members. The group met five times during the year, one of which was in person at the NEGC annual
meeting in December 2010.
In Year Four the DEM work group continued to work toward completion of an interactive website for
elementary school teams, a guide for the classroom for children with genetic conditions. This work builds on
the group’s efforts of the previous two years in which they primarily assessed the need for education about
genetic conditions among potential audiences and the best way to provide it, and conducted focus groups
with special educators to vet the project. In Year Four the group focused on 1) working with a web design
vendor and 2) developing content for the website for the initial five conditions: PKU, Sickle Cell disease,
Fragile X, Fatty Acid Oxidation Disorders, and 22q Deletion. In Year Five they will pilot, disseminate, and
expand this new resource for additional conditions.
Working with a vendor to develop the design was a multi-layered process. The goal was to present unfamiliar
and complex information in a simple manner that was compelling to educators ranging from
paraprofessionals to specialists. How the information was displayed was as important as the content itself, as
this impacts whether or not the website will actually be used. The group’s original concept of starting with
information teachers might find most relevant in the classroom – “challenge areas” (i.e. child has pain, field
trips, etc.) – and then linking to more in-depth information about genetics, became concrete within the web
design.
An important task was to finalize the name and URL address with a simple and easy to remember URL to
increase usage. The group ultimately chose the following name: GEMSS: Genetic Education Materials for
School Success and www.gemssforschools.org. They also developed a concept for the logo which will be
finalized in Year Five.
The DEM work group was fortunate to collaborate with Christine Giummo, Certified Genetic Counselor
from the University of Vermont, to write content for the website. Ms. Giummo used her expertise to address
each challenge area for each of the five selected conditions. Challenge areas included: 1) Dietary and Medical
Needs; 2) Special Education Supports; 3) Behavior/Sensory; 4) Field Trips/Special Functions; 5)
Absences/Fatigue; 6) Emergencies; 7) Additional Considerations. Ann Dillon, a special education specialist
from the Institute on Disability at UNH helped to simplify the language. Ms. Giummo also compiled links to
helpful resources.
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Focus groups previously vetted the need for the information. The DEM work group also wanted to vet the
information itself. Toward that end, they identified two condition-specific advocacy groups per condition that
were willing and able to review the content. Some groups were larger, some smaller; some were regional and
some were national. One organizational director is a member of the DEM work group, and another is on the
NEGC Advisory Committee. These new partnerships will strengthen the validity of GEMSS.
In addition to the special education project the DEM group screened an additional resource for the NEGC
website, the Genetics and Rare Diseases Information Center (GARD). GARD was determined to be not user
friendly and therefore not recommended for inclusion in the NEGC website.
One final ongoing project, the Newborn Screening Clearinghouse, occurred in conjunction with the Genetic
Alliance and their collaborative agreement with HRSA. Dr. Burke participated on this Materials Committee
and the National Advisory Council to recommend resources and represent the needs of our region.

Laboratory Quality Assurance Workgroup
The New England Newborn Screening Program (NENSP) has developed algorithms to categorize tandem
mass spectrometry (MSMS) results to better discriminate between false positives and true cases, improve the
clarity of communications to the medical home, and to better target the use of scarce specialty care resources.
To be useful for application to regions outside of the NENSP, the universality of these algorithms must be
proven in a robust manner by application to independent data sets. The project proposed to apply these
algorithms to data sets independently derived by the newborn screening labs in Connecticut, New York, and
Wisconsin. During year four, CT informed us that it was unable to continue participation in the project due
to internal reasons.
In prior years of the project, concentrations of all relevant MSMS markers were collected from CT, MA, NY,
and WI, for all specimens with out-of-range values for the following markers: C3, C5, C14, C14:1, C14:2,
C16OH, C18:1OH, C16, C18:1. During year four, analogous data were collected from MA, NY, and WI on
all remaining markers with relevance for newborn screening (C5OH, C5:1, C5DC, Leu, Cit, and Arg). Drs.
Sahai and Eaton analyzed these data according to indices and cutoffs developed at UMass. We then compared
the index-based categorizations to actual follow-up for the following disorders: 3MCC, BKT, GA-I, MSUD,
CIT-I, ASA.
Some indices could not be applied directly for categorization since some markers utilized in the index were
not tested by all laboratories. In such cases additional indices were created and cut-offs for these were
established based on the site-specific population statistics. These markers were C3, Cit, and Arg. The
categorizations were very effective for most markers but not as useful for one marker in particular. For
example, markers that showed universal applicability included C16, C18:1, C16OH, C18:1OH, C5, C5:1,
C5DC, Leu, C14:1, and C14:2. The marker that was less effective was C5:OH. An unexpected finding from
analysis of the raw data from partner laboratories was that a significant number of specimens had “0”
concentrations for some markers. In such cases we utilized the “multiples of the mean” (MOM) while
evaluating profiles and establishing cut-offs.
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Use of web-based conferences utilizing Acrobat Presenter introduced in Year 3 was utilized for sharing of
excel and PowerPoint files during web conferencing with all partners.
A summary of findings to date was presented at the Laboratory Subcommittee of the SACHDNC Meeting, in
May 2011. The New England Newborn Screening Program has already begun accompanying newborn
screening lab reports with fact sheets to the medical home that reflect the categorizations of this work. It is
anticipated that other collaborators will make similar use of these indices when the work is completed and
confirmed. The collaborators plan to submit this work as a detailed publication by the end of the grant
period, which will make available this approach to screening programs of all states and countries.

Long Term Follow Up Workgroup
The Long Term Follow Up (LTFU) Workgroup (NENSP and New England state NBS coordinators) is led
by Anne Comeau, Ph.D. and has nine members. During Year Four, they continued to focus on issues
surrounding interstate data sharing and operating principles relevant to our current and future regional LTFU
system. States continued to make progress in moving forward with both establishing the authority to collect
LTFU data (MA, ME, RI in particular) and actual data collection (MA and ME and RI). Work on the
development of IT systems for protected state-specific LTFU data that are compatible with updates to the
NENSP core data system has begun. Meetings of “condition” specific NBS workgroups have also continued
over the course of the year in order to engage specialists caring for infants and children diagnosed with
newborn screening conditions to develop and refine data collection tools and variables.
The LTFU Workgoup held a meeting as a part of the 2010 NEGC Annual Meeting in December 2010. Dr.
Inderneel Sahai presented LTFU data on children diagnosed with long-chain hydroxyacyl-CoA
dehydrogenase deficiency (LCHAD) by NBS. LTFU (age range 2-10 years) revealed that while some cases
remain asymptomatic, others had associated clinical findings such as recurrent biochemical abnormalities,
mild language delays, muscle pain on exertion, and retinal abnormalities after 3 years of age. This project will
be formally presented by Dr. Sahai at the upcoming 2011 NBS and Genetic Testing Symposium. In Spring
2011, under Dr. Sahai’s direction, a second project to evaluate the long term metabolic outcomes of children
identified with Short chain acyl-CoA dehydrogenase (SCAD) began.
Dr. Anne Comeau presented Massachusetts data as a part of the CF NBS and Care Quality Improvement
Short Course at the 2010 24th Annual North American Cystic Fibrosis Conference held in Baltimore, MD
(October 21-23, 2010). The Massachusetts CF NBS Workgroup began discussions and design of a new LTFU
project with data collection to begin in late 2011. This project will address outcomes of a subset of patients
identified by CF NBS over the course of 10 years in order to enhance the development of follow up and best
practices for this particular subset of children.
The Hemoglobin Workgroup continued to focus and build upon their LTFU activities. In September 2010,
the group hosted a successful conference, “Surviving to Thriving: Improving Long-term Outcomes in Sickle
Cell Disease.” The conference was attended by over 100 people and brought together experts from around
the county to identify best practices for improvements to patient care. Ms. Claire Hughes of NENSP and Dr.
Philippa Sprinz of Boston Medical Center also attended the International Public Health Learning
Collaborative on Hemoglobinopathies meeting held in Atlanta, GA (November 3-4, 2010). This meeting
focused on the integration of public health and clinical practice as related to hemoglobinopathies.
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Dr. Anne Comeau continued to represent the LTFU workgroup at national forums including two LTFU subcommittee meetings of the SACHDNC (January 27-28, 2011 and May 5-6, 2011), the Clinical Centers
Workgroup Meeting of the NBSTRN (October 14-15, 2010), and at the NBSTRN Effective Follow Up PI’s
and Partners meeting (March 28-30, 2011).
Focus on Long Term Psychosocial Follow-Up of Newborn Screening
In Year Four, Dr. Waisbren collected data on children with the Uniform Screening Method. The Uniform
Screening Method consists of three instruments to assess development, each of which can be administered by
non-psychologists (parents) and computer scored and interpreted:
1. Adaptive Behavior Assessment System-Second Edition (ABAS-II, for infants and adults)
2. Behavior Rating Inventory of Executive Function (BRIEF, for preschoolers to adults)
3. Behavior Assessment System for Children-Second Edition (BASC-2, for preschoolers to adults)
Dr. Waisbren gave a presentation on her work in April, 2011, to the International Neuropsychological
Society. Dr. Waisbren had collected data on 30 cases (MCAD, PKU, and Galactosemia). She included data on
children who would have been missed for referral, noting that the Adaptive Behavior Assessment System was
shown to be 94% accurate.
In the process of conducting the work, Dr. Waisbren noted that there were challenges (including insurance
company coverage for screenings) in getting metabolic clinics to participate.
During Year 5, Dr. Waisbren plans to promote the use of the Uniform Screening Method via the websites of
the NEGC, the NE Consortium, and the Psychology Network. In the future she will build on her work by
piloting the Method at two centers, one of which will be Children’s Boston. The goal is to have a “shovel
ready” vetted instrument that has buy-in from potential users.
Posttraumatic Stress Disorder (PTSD) and Newborn Screening
Dr. Joanna Fanos' work focused on understanding how best to identify the need for additional supports to
parents who are notified, post newborn screening, that their child has a serious illness. The need for this
project centered on the fact that several features of the disorder (re-experiencing, avoidance, numbing
and hyper-arousal) could impact medical care of the child as well as cause difficulties for the
family, including well siblings. Dr. Fanos' team conducted an extensive literature review and held multiple
informational interviews to identify appropriate scales and to develop a recommended protocol following a
negative outcome for newborn screening. The team recommended use of the Breslau scale6 (a seven item,
Y/N response questionnaire) as an initial screener for parents. Parents who screen positive on the scale
should complete either an Adult Self Report Scale7 or an Adult Interview8 in order for a more rigorous
assessment to be made concerning the need for additional supports.

Breslau, N., Peterson, E.L., Kessler, R.C., Schultz, L.R. Short screening scale for DSM-IV posttraumatic stress
disorder. American Journal of Psychiatry. 1999 156:908-11.
7 Recommended scales include: Davidson Trauma Scale (DTS), Distressing Events Questionnaire (DEQ), Impact of
Events Scale-Revised (IES-R), Los Angeles Symptom Checklist (LASC), Modified PTSD Symptom Scale (MPSSSR),
Penn Inventory for Posttraumatic Stress Disorder (Penn Inventory), Posttraumatic Diagnostic Scale (PDS), PTSD
Checklist (PCL), Screen for Posttraumatic Stress Symptoms (SPTSS), Trauma Symptom Checklist-40, and Trauma
Symptom Inventory (TSI).
6
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Ethical, Legal and Social Issues
Through its multiple endeavors, the NEGC seeks to address relevant public policy and ethical, legal, and
social issues (ELSI) affecting individuals with genetic conditions, their families, and health care providers and
educators. During Year Four, the following areas were addressed:
Ethical Issues
Work around the creation of a central data resource to improve understanding of patient services raised many
discussions around the appropriate use of data for improving health care quality. During Year Four, NEGC
staff met with a range of national, regional, and state level providers in order to ensure appropriate steps were
taken to safely manage and appropriately utilize patient information. Additionally, in preparing for its Face
Forward Summer Conference for Youth, members of the Transition Workgroup took an important step in
addressing the role of youth participation in program development by creating a youth council that became
actively involved in planning the event.
Legal Issues
Advances in this area continued with the QI workgroup's exploration of forming a patient safety organization
and subsequent pursuit of BAA agreements among participating clinics as well as LTFU work to solidify an
agreement with the State of Rhode Island in Year 4 to pursue long term data tracking. The Birth Defect
Consortium pursued integration of data on birth defects from Maine, Connecticut, Rhode Island, New
Hampshire, and Vermont. Dr. Eaton's work to launch an Emergency Preparedness Symposium explored
some of the initial areas to address in developing a regional emergency preparedness plan. Lastly, Michelle
Winchester completed her work analyzing differences in New England state laws concerning the use of
protected health information from newborn screening for quality improvement and research purposes9.
Social Issues
The NEGC impacted the social context of healthcare for individuals with genetic conditions in a variety of
ways. Joanna Fanos published her work on the impacts of genomic information on childhood sibling
relationships. The Birth Defects Consortium outreached to WIC centers in the New England States to
educate groups about the importance of folic acid. Patricia Rissmiller worked to expand our understanding of
genetic awareness among minority populations, and Victoria Odesina laid the groundwork for improving
home health care and quality of life for adults with SCD. Dr. Waisbren created the MCADD Educator’s
Guide to help teachers better understand the disorder and prevent potential problems from occurring. The
NEGC supported the development of the National Tay-Sachs and Allied Diseases Association website.
Lastly, the work of the DEM group to create an online resource for special educators will result in a very
valuable information resource that will be made available to educators across the nation.

8

Recommended interviews include: Clinician-Administered PTSD Scale (CAPS), PTSD Symptom Scale–Interview (PSS-I),
Structured Clinical Interview for the DSM-IV Axis Disorders (SCID PTSD Module), and Structured Interview for PTSD (SI-PTSD)
9
A copy o f the report is available here:
http://www.negenetics.org/Libraries/Ongoing_materials/State_Laws_of_NE_Use_Disclosure_of_Genetic_NBS_Information_
Winchester_Oct_2010.sflb.ashx
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Policy Issues
As a result of LTFU work in Rhode Island, the ability to share LTFU data has now been formally established.
Along with Massachusetts and Maine, this will continue to have multiple positive impacts on the ability of the
Newborn screening program to track health outcomes, identify best practices, and ultimately improve the care
of individuals with genetic conditions. NEGC's support of partner's work, either through letters of support or
direct funding of innovative grants, led to a range of improvements impacting the policy arena. Support for
the American Academy of Pediatrics will help to ensure better integration of genetic medicine practices
among primary care providers. New research was published creating a national profile of children with Down
syndrome, and Joanna Fanos completed her recommendations for brief and more in-depth mental health
screens for parents receiving a medical diagnosis for their child. Dr. Sahai published some of the early
experiences of long term follow up efforts to ensure quality of care of individuals. Lastly, work on Assessing
Genetic Workforce Capacity continued in Year 4 and resulted in several policy recommendations.
ELSI issues will continue to be reviewed annually by the NEGC Advisory Council which will advise on
potential new directions for the collaborative to pursue.

Evaluation Activities
During Year Four, the evaluation of the NEGC was led by Peter Antal, Ph.D. Primary roles during the fourth
year of the collaborative focused on: providing ongoing review of activities, summarizing project activities via
evaluation reports, promoting coordination with the national evaluation initiative, and conducting the third
annual stakeholder survey.
Ongoing Review of Activities
Peter Antal has actively participated in NEGC meetings, including ongoing planning meetings and meetings
with the Quality Improvement Learning Collaborative, Collaborative Council, Advisory Council, as well as
monthly meetings with the principal investigator, project manager, and workgroup chairs. The focus of his
participation in these meetings is to provide historical context to guide decision making, technical support in
areas of research, and suggest areas of follow-up by staff.
Evaluation Reporting
During the past year, the Year Three Project Report and Year Four Annual Meeting report was posted as was
the Year Three Stakeholder survey. All reports were provided to staff for review and feedback prior to final
publication as public documents on the project’s website. Reports include:
 Results of Stakeholder Survey for Project Year 3: Dec. 2010
 Annual Evaluation Report for Project Year 3: Dec. 2010
 Summary of the Year 4 Annual Meeting: Feb. 2011
In addition to the above reports, Dr. Antal also supported HRSA's strategic planning process by conducting a
survey and a facilitated discussion with other regional collaboratives involved in improving genetic services.
The summary of recommendations can be found in the document, Strategic Planning Recommendations for
HRSA: Mar. 2011, available on the National Coordinating Center's website (www.nccrcg.org).
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As shown in Figure 2 below, online views of evaluation material peaked in January (27 unique views) and
March of 2011 (52 unique views).

Fig. 2 NEGC Evaluation Pageviews
Nov. 2010 Through May 2011
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National Benchmarks
Dr. Antal has continued to represent the New England region by monitoring and updating national
benchmarks for regional genetics programs. Dr. Antal has participated in conference calls and has regularly
solicited input from NEGC staff on key issues leading to their creation and utilization. Reporting for the
national benchmarks is based on regional activities between Dec. 1, 2009 and Nov. 30, 2010. Results are
provided below:
 Outcome Measure A1: Increase in the percentage of states/territories in the region with
collaborations facilitated by the Regional Collaborative between primary care providers (PCPs) and
specialty (including genetic) providers to improve care coordination for people with heritable
disorders.
o Result: 100%. All New England states were involved in collaborations facilitated by the RC
between PCPs and specialty providers. Examples of collaboration include:
 Education and awareness building regarding medical home occurred through the
NEGC annual meeting and the New England Consortium of Metabolic Programs
annual meeting.
 Collaboration between medical home workgroup and transition work group targeted
care in both specialty and primary care settings. Dr. Susan Waisbren has used the
Transition Plan documents with 10-15 patients and has posted these care plans on the
New England Consortium of Metabolic Programs website. Additional material
reviewed and posted to the website included: Acute Illness Protocols, Newborn
Screening Guide for Prenatal Educators, Newborn Screening Prenatal Curriculum,
Transition to Adult Care guide, Transition Plan, and many others.
 In Massachusetts, Dr. Waisbren, via NEGC’s innovative projects program, led the
Personal Transition Health Plan Project at Children’s Hospital Boston. The long-term
goal of this project was to develop and pilot a practice model that ensured that every
24

adolescent and young adult patient seen at a genetics or metabolic clinic had thought
about and documented a plan for on-going health care that addressed the specific
needs of his or her specific condition, with a focus on symptoms that are relevant to
adults.
 Dr. Burke attended the annual NCHPEG meeting as the American Academy of
Pediatrics representative. She presented the data from our focus groups on the special
educators' tool at that meeting. Dr. Burke reported back to pediatricians and pediatric
clinical geneticists on the NCHPEG meeting presentations and initiatives.
 NEGC’s workgroups have begun integrating their efforts (Medical Home, Transition,
and Quality Improvement). The medical home pilot project was implemented in
2010. Key staff (Dr. Carl Cooley, Dr. Chris Stille, Dr. John Moeschler, Dr. Wendy
Smith) have collaborated with the annual metabolic consortium meeting and have laid
the foundation for more integrated work with the NEGC.
 Joanna Fanos’ work on parent perspectives of the diagnostic and follow up process
helped to identify a series of recommendations that can provide needed supports for
families dealing with the challenges of a new diagnosis.
 Dr. John Moeschler has been working with the QI workgroup on developing a
standard set of quality improvement data points that will be collected by multiple clinic
sites. Central to this effort is the researching and potential creation of a Patient Safety
Organization (PSO) and/or data sharing business agreements that will enable the
sharing of information among providers to aid in quality improvement efforts in the
region.
 Dr. Moeschler has collaborated with a planning team to create the initial framework
and pilot tools for a new Quality Improvement Learning Collaborative serving the
New England region.
 Stephanie Miller of Dartmouth Medical School has formed the New England Birth
Defects Consortium to facilitate project and data collection coordination among New
England birth defect registry programs. The aim of the consortium is to improve
services for infants and children with birth defects by promoting regional
collaboration in surveillance data sharing, birth defects research, prevention activities
and health care quality improvement.
 Outcome Measure B1: Increase in the number of genetic services visits and NBS follow-up specialty
visits provided to individuals/families through distance strategies implemented by the regional
collaborative.
o Result: NA. NEGC did not provide support for service visits through RC implemented
distance strategies during this period.
 Outcome Measure C1: Increase in the percentage of states/territories in the region that have received
current materials or other assistance from the RC on emergency preparedness/contingency planning
for newborn screening (NBS) and genetic services.
o Result: 100%. Departments of Health / NBS programs in each of the states have received a
New England Newborn Screening Program COOP Plan. Stakeholders were involved in the
development of an Emergency Preparedness workshop held on April 1, 2011.
 Outcome Measure D1: Increase in the percentage of states/territories in the region that have
evaluated and made recommendations on implementing the ACHDNC recommended NBS panel.
o Result: 100%. All states in the region have evaluated and made recommendations on
implementing the ACHDNC recommended NBS panel. Note that this process is independent
of NEGC activities for the reporting period. Only Massachusetts, Rhode Island, and
Connecticut have evaluated and made recommendations on SCID.
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 Outcome Measure E1: Increase in the percentage of states/territories in the region with systems in
place to track entry of newborns into clinical management for newborns who are diagnosed with
conditions mandated by their State-sponsored newborn blood spot screening programs.
o Result: 100%. All states in the region have systems in place to track entry into clinical
management for newborns diagnosed with conditions mandated by State-sponsored newborn
blood spot screening programs. Note that this process is independent of NEGC activities for
the reporting period.
 Outcome Measure E2: Increase in the percentage of states/territories in the region with systems in
place to track entry into clinical management for newborns who are diagnosed with hearing loss
through their State-sponsored newborn hearing screening programs.
o Result: 100%. All states in the region have systems in place to track entry into clinical
management for newborns who are diagnosed with hearing loss through their State-sponsored
newborn hearing screening programs. Note that this process is independent of NEGC
activities for the reporting period.
 Outcome Measure E3: Increase in the percentage (number) of states/territories in the region with
systems in place to track receipt of clinical services and/or health outcomes for children who are
diagnosed with condition(s) mandated by their State-sponsored newborn blood spot screening
program and/or with hearing loss through their State-sponsored newborn hearing screening
programs.
o Result: 17%. Only Massachusetts meets the criteria of having a long term follow up system
for all conditions in each area (metabolic, endocrine, hemoglobin, cystic fibrosis, and hearing)
mandated by the State-sponsored newborn blood spot screening program. States in the region
provide variable extents of long term follow up tracking for genetic conditions identified by
NBS. The variety is dependent on the state and the particular condition. 5 of 6 states are
working with the New England Newborn Screening Program (NENSP), following and
modifying the model set in Massachusetts to ensure LTFU in a manner that allows quality
assurance and quality improvements.
 Outcome Measure F1: Increase in the percentage of states/territories in the region whose NBS
programs disseminate “just-in-time/point-of-care” information on specific heritable disorders to
primary care providers (PCPs).
o Result: 100%. All state NBS programs in the region disseminate information on heritable
disorders to primary care providers. Note that this process is independent of NEGC activities
for the reporting period.
 Outcome Measure G1: Increase in the percentage of Regional Collaboratives that have completed a
regional genetic services plan.
o Result: 100%. NEGC’s plan is outlined in its annual grant application to HRSA. The plan is
tied to a series of objectives, action steps, timelines, and resources that are followed to carry
out NEGC’s mission. The goals and strategies adopted by NEGC are reviewed and updated
annually by the Advisory Council.
 Outcome Measure G2: Increase in the percentage of Regional Collaboratives that have reviewed
and/or updated their regional genetic services plan at least every two years.
o Result: 100%. The plan is reviewed on an annual basis by the project’s collaborative council,
advisory board, and stakeholders. Initiatives proposed for 2011 were reviewed during the
December, 2010 annual meeting of the collaborative. Multiple recommendations were
provided on next steps for the collaborative during 2011 which the staff will review and
incorporate as appropriate into grant activities.
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NEGC Stakeholder Survey for Project Year Four
For Year Four, the evaluator again worked with project staff to update and implement the NEGC stakeholder
survey. The survey was administered online between October and November 2011. A summary of the results
follows.
SUMMARY OF FINDINGS FROM THE YEAR FOUR STAKEHOLDER SURVEY
[Executive Summary excerpted from New England Genetics Collaborative, Results of the Partner Survey for Project Year Four
by Peter Antal, Ph.D. (January, 2012). For the full report, please download from
http://www.negenetics.org/AboutUs/Evaluation_reports.aspx
To facilitate feedback from its stakeholders, the NEGC conducts an annual survey to identify concerns,
document how the project is doing, and solicit suggestions for improvement. One hundred-forty-one email
invitations were sent out between October and November 2011 to stakeholders of the New England Genetic
Collaborative (NEGC). Of these, one opted out and 63 provided responses (45% response rate).
Since the 2009 report, there was improvement in two important areas. When asked whether they had a clear
understanding of the NEGC's mission, 73% agreed (vs. 60% in 2009). Concerning whether the NEGC had
made substantive and clear progress in achieving its mission, 72% agreed (vs. 47% in 2009). Feedback on the
project's evaluation reports was generally positive with 67% to 70% of respondents indicating that each of the
reports helped them understand the progress and challenges of the initiative (vs. 60% to 75% in 2009).
Feedback from the Advisory Council was high this year, with 13 members participating. Most participants
(>75%) felt that there was a good spirit of cooperation, that meetings were well run, that the RCC provided
excellent support and responded effectively to questions, and that the Advisory Council was achieving its
main objectives.
Project recommendations highlight the need for continuing to strengthen communication efforts of the
NEGC, identifying new collaboration opportunities for members of the Advisory Committee, making
effective use of potential partner contributions, improving consumer/family representation in regional
change, pursuing sustainable initiatives, addressing multiple barriers to care for families, and improving access
to NEGC resources.

COMPLETION OF OBJECTIVES IN YEAR FOUR
Table 3 provides a complete list of the objectives set forth by project staff at the beginning of the project year
(with modifications based on changes in the project) as well as the status of each objective as of June, 2011.
Measures of objective “status” relative to implementation over the course of the 5 year project are defined by
the following key: 1. Completed as planned, 2. Completed - deviated substantially from plans, 3. In progress satisfactory, 4. In progress - unsatisfactory, 5. Initiation of activity deferred, 6. Activity abandoned, 7. Not
scheduled to initiate this period, 8. Insufficient documentation available. Additionally, a review is provided on
the relative success of the objectives during Project Year Four. Review results are defined as:
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 Successful (34 of 54): All definitions of success for an objective have been fully met or the results of
the activity in question fulfill the intent of the measure.
 Partially Successful (18 of 54): Definitions of success for the year only partially met. Although not
fully realized, substantive progress has been made in a number of core areas with fulfillment of the
goal expected by the next project year.
 Unsuccessful (2 of 54): Although some work on an activity may have been done, primary components
of an activity targeted for the year were not substantively addressed within the time period. Lack of
success may be due to a number of factors, including lack of participation by certain groups, delays in
timeline for other project components, and the need to shift project priorities such that other
components could be fulfilled in Year Four.
Table 3: Status of Goals and Objectives of the NEGC, Project Year 4
ESTABLISH AND MAINTAIN NEGC

No.
1

2

3

Objective

Project
Status

Continue
implementation of
core administrative
supports to the
NEGC

3

Continue close
collaboration with
WG and AC

3

Develop and
implement a
communications and
outreach plan for the
NEGC

3

Yr. 4 Definition of
Success
NEGC meets yearly
objectives.

Yr 4 Results
Review: Successful
All core staff activities completed
during course of year.

Work Group and
Advisory Committee
members feel supported
in the work they do and
have access to the
resources they need to
accomplish their goals.

Review: Successful

Stakeholders report
satisfaction with being
able to voice their
opinions and feel that
they've been heard.

Review: Successful

A majority of
stakeholders understand
the NEGC's mission and
the steps it is taking to
achieve that mission

Meetings are held regularly and
supports provided when requested
as resources allow. 89% of
Stakeholder Survey respondents
from the Advisory Committee
indicated that the RCC provides
excellent support.

A majority (74%) of participants
at the 2010 annual meeting felt
they had an opportunity to share
their perspective.
73% of respondents of the Year 4
Stakeholder survey felt that they
had a clear understanding of
NEGC's mission and steps it is
taking to achieve that mission.
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4

5

Maintain, update and
enhance NEGC
website

Implement Special
Projects

3

3

New groups and
individuals are
represented on the
NEGC stakeholder list.

Review: Successful

The NEGC stays current
with state, regional, and
national level
developments.

Review: Successful

Between Yrs 3 and 4, participation
of stakeholders (defined by
mailing list) increased from 75 to
140.

Website is maintained and
updated continuously.

Stakeholders have
information necessary to
keep informed of all
project developments.

Review: Successful

Website is utilized by
growing numbers of
individual users.

Review: Successful

Genetic Workforce study

Stakeholders received 3 quarterly
updates, mid-year report, and an
annual report describing project
progress.

Starting Nov.2011 with the new
website, unique users increased
from 28 to 254.
Review: Successful
Research and analysis completed
during Year 4 for the New
England region and
recommendations provided for
improvement of the workforce.

Emergency Preparedness
Conference

Review: Successful

Launch Advocacy
Committee

Review: Successful

Event held April 1, 2011 with 23
participants.

Group met for the first time on
May 9, 2011 to identify core issues
and outline next steps.
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QUALITY IMPROVEMENT

No.
1

Objective
Registry will be
implemented for all
patients with
developmental delays
at all 5 sites.

Status
3

Yr. 4 Definition of
Success
All sites entering
complete, quality data on
all patients meeting
criteria.

Yr 4 Results
Review: Partially Successful
2 sites and four medical geneticists
entering data, 1 site in IRB review,
340 total patients entered as of
Dec. 2011.
Data have been analyzed and
poster will be presented at
ASHG/ISHG annual meeting in
Oct 2011 in Montreal

2

3

Create a PSO to host
data collected from
clinic sites and/or
obtain exemption
letters for each site
through CPHS

Implement QI report
structure

3

Updated Definition: Legal
framework in place
enabling hosting and
utilization of data from
participating sites.
Was: ARHQ website lists
all approved PSOs / sites
participate in registry
under exemptions

1

Report format in Registry

Review: Successful.
PSO efforts were dropped after
multiple discussions with national
and regional partners as it was
determined that the developments
of BAA agreements would be a
better fit for the NEGC's work.
BAA agreements in place for 2
sites (and 4 medical geneticists)
and templates created for IRB
waivers as not human subjects
research but quality improvement
activity.

Review: Successful
The vendor hosting the database,
GVT, has created and
implemented the database, with
revisions added, as needed.
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4

QI data submitted,
analyzed and reported
from all five current
clinical genetics sites.

3

Updated Definition:
Registry in place and
utilized by all 3 clinical
sites
Was: Registry in place and
utilized by all 5 clinical
sites

5

6

7

Establish the
Metabolic Quality
Improvement
Learning Collaborative

Establish quality
improvement clinical
process and outcomes
for patients with
metabolic disorders

Metabolic quality
improvement registry
will be established
(customization of
Genetics QI registry).

1

3

3

10 metabolic centers will
send teams of 2-3
members each to QILC
(3 meetings during the
year).

Review: Partially Successful
2 sites are submitting data to this
project; a third is in IRB review.
No additional sites are being
considered at this time.
Data have been analyzed and an
abstract presentation has been
accepted by ASHG for Oct. 2011.
Additional analyses/reports will
be presented at the QI work
group meeting in Nov. 2011.
Review: Partially Successful
9 centers initially agreed to
participate in the QILC, 5 centers
have sent teams to full meetings
of the QILC. 7 centers have
provided summary data. Two face
to face sessions were held during
the project year: Feb., 2011 and
April, 2011; a third was held
October 2011.

Support webinars
between learning sessions
will support teams

Review: Successful

A common set of data
will be agreed upon.

Review: Successful

Condition-specific
measures for at least 7
metabolic disorders or
problems will be set
forth.

Review: Partially Successful

Registry exists and
contains all the data
elements defined by the
QILC.

1 webinar held between sessions
one and two of the QILC. A
second was be held in June 2011.

Data set agreed upon.

Agreed-upon additional specific
measures set forth for 2
conditions.
Review: Partially Successful
Substantive progress made during
Year 4. Data sheets for PKU and
MCAD were developed. These
collection sheets have been
submitted to GVT for
implementation into electronically
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accessible data base in Year 5.
8

Metabolic centers will
be members of the
PSO and/or will
obtain CPHS
exemption letters and
have HIPAA BAAs in
place.

3

PSO is in place / letters
are obtained or
Membership contracts are
in place for all
participating centers

Review: Partially Successful
Group decided that no linkage
would be established at this time.
Two Centers will be involved in
QI activities for both Metabolic
and GDD/ID. Those providers
will access the Registry by QI
activity.

TRANSITION

No.
1

2

3

4

Objective

Status

Develop
assessment tool
for measuring
successful
transition to
medical home

3

Continue to
publish, present,
and disseminate
transition related
agenda

3

Create materials
for youth and
adults on
metabolic
disorders

5

Hold conference
for adults with

6

Yr. 4 Definition of
Success
Written list of criteria
identified.

Yr 4 Results
Review: Partially Successful
Collaborative work with Dr. Cooley
continued through Year 4 with
resolution achieved concerning
whether a medical home was able to
handle a transition. The next phase
of the work will be to determine
indicators of success that a
transition has "successfully"
occurred.

Agenda promoted via
published articles and
presentations

Review: Successful

Creation of Fact Sheets
that list issues for adults
with these disorders
written for a lay
audience. 8 fact sheets
will be produced in
Year 4.

Review: Partially Successful

Conference held.

Review: Unsuccessful

Publications, presentations, and
materials related to Transition were
shared in a range of venues (website,
conferences, regional and national
teleconferences).

Dr. Waisbren continued
development of 4 fact sheets in Year
4. The new worksheets are due to be
released once the new ACMG forms
are completed and information has
updated and adapted for a lay
audience.
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metabolic
disorders

5

6

7

8

A separate conference for adults
with metabolic disorders was not
held in Year 4. Efforts transitioned
to try and support additional
learning opportunities for
youth/young adults. A separate
grant was secured for a conference
in January 2012 for adults with
PKU.

Continue to
monitor new
advances in
transition
programs –
especially through
special education
initiatives

4

Assessment of
best practice
protocol by
metabolic
physicians and
dieticians and
other professional
staff

1

Continue to Pilot
transition practice
at Children’s
Hospital

1

Leadership
training for teens
with genetic
disorders. Program

1

Transition practices are
summarized for
genetics and
metabolism
.

Review: Partially Successful
Although staff remain well informed
of current transition practices and
actively support their
implementation, a formal summary
was not updated in Year 4.

Reviews received by at
least 3 professional
staff (dietician, nurse,
fellow).

Review: Successful

10 patients participate
at Children’s Hospital.

Review: Partially Successful

Leadership training
takes place.

Protocol reviewed by Dr. Levy, Fran
Rohr, and Leah Hecht. It was
determined that the protocol
required too many resources to
implement at this time.

As a result of piloting the transition
tool, it was determined that the
transition tool would be better
implemented in a different setting as
there were too many barriers to
implementation in the hospital
setting (fewer than 10 patients had
participated). The Metabolic Basics
resource received hundreds of hits
on the New England Consortium
website indicating that the resource
was being accessed in alternative
ways.
Review: Successful
The Teen Challenge weekend was
held in July 2010. Nine youths
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at Teen Challenge
Weekend

9.

10.

11.

worked to build confidence,
strengthen bonds, challenge comfort
zones and develop some of the skills
needed to manage complex health
conditions.

Participate in
effort to improve
quality in
metabolic clinics
via learning
collaborative
methodology

3

Continue to
represent
transition activities
on LTFU as
needed.

3

Collaborate with
the National
Transition
Resource Center
being developed at
the Center for
Medical Home
Improvement

3

Plan developed, ratified
and implemented by
QILC planning group
and expert panel

Review: Successful

Improved access to
assessment for all
adults with genetic
conditions in New
England

Review: Successful

Seek out new
opportunities and
collaboration

Review: Successful

Dr. Waisbren supported the QILC
throughout Year 4 by providing
feedback on project material.

Dr. Waisbren continued work on
the Uniform Screening Method by
collecting data on 30 cases,
analyzing and presenting the results.

Integration with the NHCTC is
ongoing. Of note, NHCTC staff
have been directly integrated into
the Transition Workgroup.

MEDICAL HOME

No.

Objective

Status

1

Begin field test of
the care
coordination
project in two
specialty clinic
catchment areas

6

Yr. 4 Definition of
Success

Patients and families
are recruited into trials
of the care planning
tool at Children’s
Hospital Boston (10
patients / families) and
one other metabolic /
genetics clinic (at least 5
patient / families).

Yr 4 Results

Review: Unsuccessful
After review of some of the barriers
to implementation of the pilot (the
previous project lead transitioned to
a new appointment in another
region, and some of information for
the care planning tool was already
being captured by some
components of the care model), the
workgroup decided to abandon this
effort and pursue a new objective to
improve care coordination in the
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region (Obj. 2).
Process data are
collected at the
Children’s Hospital site
including number of
plans implemented,
number of visits
documented.
2

3

4

New Objective:
Assessment of
communication
between primary
care providers,
families, and
specialists

3

Convene at least 3
meetings of the
MHWG during
Year 4.

1

Continue to
integrate meetings
and work with the
Transition
Workgroup

3

Survey tool designed
and fielded.

Two conference calls
and one face-to-face
meeting occur.

Annual face-to-face
meeting in December
2010 is a joint meeting
of the two work
groups.

Review: Unsuccessful
Activity dropped.

Review: Successful
In order to further work in the care
coordination area the group decided
to seek clarification of the care
processes that were in place and
how they were communicated
between providers and families as
well as between providers and
specialists. A tool was developed
and fielded for the first survey, with
analysis and completion of the
second survey expected in Year 5.
Review: Partially Successful
Group met two times in Project
Year Four (December 2010, May
2011).
Review: Successful
A joint meeting was held December,
2010 and May, 2011

DISSEMINATION, EDUCATION AND MARKETING

No.

1

Objective

Continuously
improve
educational
products and
activities for
providers and
consumers

Status

3

Yr. 4 Definition of Success

Current model finalized
and dissemination plan
created based on
recommendations

Yr 4 Results

Review: Successful
Substantive work was carried out
during Year 4 to improve the
resources and capacity of the new
GEMSS tool.
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2

3

Create web portal
based on tool
"Children with
Genetic/Metabolic
Conditions in the
Educational
Setting"

3

Improve
utilization of
genetic education
materials

3

Expansion of modules
utilized in educational tool
for special educators.

Review: Successful

Revise tool for
pediatricians and parents.

Review: Unsuccessful

Tool posted on website

Multiple modules were researched
and collaboratively reviewed for
incorporation.

Activity to be reviewed during Year
5.
Review: Partially Successful
During Year 4 the workgroup
developed the infrastructure and
basic schematics for the new
website. The tool will go live in Year
5.

Identification of new
resources / tools to be
linked to the NEGC
website and distributed to
stakeholders

Review: Partially Successful
During Year 4, the group reviewed
the Genetics and Rare Diseases
Information Center (GARD),
determined that is was not user
friendly and therefore not
appropriate for inclusion on the
NEGC website.

DEMONSTRATE EFFECTIVE COLLABORATIONS

No.
1

Objective

Status

NEGC continues
to participate in
national work
groups

3

Yr. 4 Definition of
Success
The NEGC is actively
represented on a national
level by staff and NEGC
constituents and
contributes to the
improvement and
coordination of genetic
services.

Yr 4 Results
Review: Successful
Project directors and workgroup
chairs are involved in one or more
national groups engaged in
transforming genetic services.
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2

3

Link with affiliated
programs (LEND
and AUCD)

3

Represent genetics
issues to wider
healthcare system

3

MOAs developed with
participating programs
identifying methods of
collaboration.

Review: Partially Successful

Additional health care
fields are educated about
the needs of individuals
living with genetic
conditions.

Review: Successful

Public Health Genetics
and Genomics is
integrated into other
academic course work

Review: Successful.

In project Year 4, an innovative
project has been funded with the
LEND program. Staff actively
sought to integrate NEGC activities
into the NH LEND program, with
new collaborations to take place
during Year 5.

Presentations made to AMCHP,
NCHPG, and participation in a
Genetics Blog. Work initiated to
better integrate genetic services into
each New England state's 211
system.

Areas of involvement include:
administering a course on public
health genetics, providing support to
UNH's MPH program, and a
presentation to AMCHP.

INNOVATIVE PROJECTS PROGRAM

No.

Objective

Status

1

Monitor
innovative grant
awardees including
new micro grants
to spur consumer
involvement.

3

Release, award and
monitor grantees

1

2

Yr. 4 Definition of
Success

Yr 4 Results

A common process is
established and
continuously improved
for the review, selection
and monitoring of
awardees that is agreed to
by all members of the
review committee

Review: Successful

Grant Cycle completed.

Review: Successful

Monitoring and updating of the
grant process has been continually
implemented.
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for 2010-11

3

4

Grant cycle successfully completed.

Work with
grantees to
develop poster
presentations
(regular grants) /
brief summaries
(micro grants)

1

Confirm award
amount and issue
RFP for grant
cycle 5

1

Poster presentations /
brief summaries
developed that represent
and convey the spirit of
the innovative projects
program.

RFP issued.

Review: Successful
4 Innovative grants were awarded
Poster presentations created,
reviewed by management staff and
Advisory Council.
Review: Successful
Grant cycle 5 process was
implemented.

ETHICAL, LEGAL, AND SOCIAL ISSUES

No.
1

2

Objective

Status

Address ELSI
issues within
workgroups as
well as through
special projects

3

Discuss ELSI
issues within the
RCC network.

3

Yr. 4 Definition of
Success

Yr 4 Results

NEGC appropriately
integrates ELSI issues
within its work and
actively pursues projects
that improve the field of
genetics in this area.

Review: Successful

Issues raised and
discussed, NEGC lessons
learned shared with the
network

Review: Successful

Examples: Ethical (review of patient
data utilization to improve service
quality, involvement of youth in
planning activities), Legal
(establishment of BAA agreements
to enable the work of the QILC),
Social (education of groups across
the New England region on the
importance of folic acid), Policy
(addition of Rhode Island to the
LTFU network).

ELSI issues are reviewed on an
ongoing basis.

LABORATORY QUALITY ASSURANCE

No.
1

Objective
Continued
representation of
quality control

Status
3

Yr. 4 Definition of
Success
Full participation in
meetings

Yr 4 Results
Review: Successful
Dr. Eaton continues to participate
on a number of regional and
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workgroup in
regional and
national forums
2

3

4

national initiatives (eg. NBSTRN,
SACHDNC).

Request and
analyze labspecific data on
marker descriptive
statistics (means,
standard
deviations, etc.) on
~ total of ~
50,000 newborns
from WI and NY.
Determine
adjustments to
category index cutoffs as
appropriate.

3

Analyze the raw
data submitted,
using lab specific
cutoffs as
appropriate. Add
C4, C5DC,
C5OH, C%:1,
multiple
acylcarnitine
elevations in same
sample, Cit, ASA

3

Hold regular
conference calls
and face-to-face
meetings, as
appropriate, to
review the data
submitted with the
partners, and
compare index
categorizations
with follow-up
data on final
diagnoses.

1

Data received and
reviewed.

Review: Successful
Substantive analysis work
undertaken, with wrap up of analysis
work to be completed in Year 5.
.

Additional analysis tables
created, new indices
possibly identified.
Evaluation of such tables
may suggest additional
index possibilities beyond
the indices currently used
by the NENSP.

Meetings held. Target
web-ex meetings in Sept.,
Nov., Jan, and face-toface meeting in March,
possible web-ex in May

Review: Successful
New detailed data tables were
produced, analysis completed on

3MCC, BKT, GA-I, MSUD,
CIT-I, ASA.

Review: Partially Successful
Full meeting of the group held in
May.
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5

Present
preliminary
findings to Lab
Subgroup
Committee of
SACHDNC

1

Presentation

Review: Successful
Presentation made in May, 2011.

LONG TERM FOLLOW-UP

No.

Objective

Status

1

Continued
representation of
LTFU workgroup
in regional and
national forums

3

Continue to
facilitate stepwise
implementation of
activities leading to
full regional
participation in
long term followup

3

2

3

Continued Data
Collection and
Expansion of Data
Collection
Activities

Yr. 4 Definition of
Success
Full participation in
meetings

Yr 4 Results
Review: Successful
Dr. Comeau continues to participate
on a number of regional and
national initiatives (eg. NBSTRN,
Institute of Medicine, CF/SCID
conferences).

3

Continued education of
state teams (NBS
Advisory committees)
about Massachusetts and
Maine experience with
implementation.

Review: Successful

Facilitating Workgroups
and reports back to state
teams from work groups

Review: Successful

Continue to legal counsel
from each state in the
discussion of method for
implementation, which
may be by Charter or by
other agreements between
and among states.

Review: Successful

Subcontracts established
with Maine and Rhode
Island.

Review: Successful

State specific data
modules created and
integrated.

Review: Partially Successful

Primary focus during Year 4 was on
collaborations with Rhode Island.

Primary focus during Year 4 was on
collaborations with Rhode Island.

Rhode Island agreed to participate
in the LTFU process.

Minimum data set defined. Updated
based on ongoing review of
information. Maine and Rhode
Island contracts in place.

These modules are being created in
conjunction with a very large data
system replacement by the NENSP
(otherwise internally funded). This
project will not be complete during
this year, and so full implementation
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of the LTFU accessibility aspects
will occur after the grant year is
completed
4

5

Data Analyses and
Publication of
Analyses

Enhancing
Development of
Best Practices

3

3

Data analysis prepared for
QI at the clinic and
program levels

Review: Successful
Analysis reports provided back to
Mass. and Maine clinics. Reports run
on MCAD and VLCAD. CF clinics
received reports and inquiries.
Hemoglobin clinics received reports
and inquiries. Metabolic clinics
received reports and inquiries. A
special report on LCHADD has also
been presented to Metabolic Clinics
in preparation for publication.

Manuscripts developed
documenting findings.

Review: Successful

Hgb conference to
facilitate development of
best practices.

Review: Successful

Development of best
practices by clinical
workgroups

Review: Partially Successful.

Genetics in Medicine paper
published.

Hgb conference held in September,
2010 focused on identifying best
practices for improvements to
patient care; attended by over 100
people from across the country.

In process. None of the workgroups
have established best practices. Hgb
would like an organization similar to
the CF foundation. Data collection
is based on the CDC’s RUSH
program. Each group (Hgb,
Metabolic, CF) is structured
similarly in that they each have
clinician advisors. They differ in the
questions they are trying to address
or document.

QUANTITATIVE AND QUALITATIVE EVALUATIONS

No.

Objective

Status

1

Gather data on
program activities
and outcomes and
provide ongoing
feedback to
project staff and

3

Yr. 4 Definition of
Success
Management staff report
evaluation support has
been an effective aid in
decision making and
program improvement.

Yr 4 Results
Review: Successful
Management Staff Review:
Evaluation and survey data are used
to inform NEGC activities.
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funder on project
progress.
2

3

4

Conduct annual
stakeholder survey

1

Complete semiannual and annual
reports which can
be used by staff to
improve project
outcomes

3

Participate on
national outcome
measurement
efforts

3

A majority of stakeholders
participate in the survey
process and provide
recommendations for the
project's improvement

Reports completed and
utilized by staff to
improve project outcomes
and utilized by
stakeholders to stay
informed of project
progress.
NEGC is actively
represented on national
measurement efforts.

Review: Partially Successful
Although there was a substantive
increase in the number of
respondents (42 to 63), the
participation rate of NEGC
stakeholders for the Year 4 Survey
was 45%. Substantive feedback
received on potential improvements
and future directions for genetic
services in the New England region.
Review: Successful
Yr 3 Report and Yr 4 Mid-Yr report
completed and reviewed by staff.

Review: Successful
NEGC was represented on all
meetings and provided information
for all national level reporting and
discussions.
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OBJECTIVES FOR YEAR FIVE
Table 4 provides a list of objectives to be completed by each of the relevant workgroups and administrative
teams for Year Five of the NEGC project. The status of each objective will be updated by the Project
Manager on a monthly basis during meetings with the various Workgroup chairs using the following key: 1.
Completed as planned, 2. Completed - deviated substantially from plans, 3. In progress - satisfactory, 4. In
progress - unsatisfactory, 5. Initiation of activity deferred, 6. Activity abandoned, 7. Not scheduled to initiate
in period. Workgroup chairs have established a series of performance measures to document successful
achievement of each of their objectives.
Table 4: Year 5 Goals and Objectives
Establish and Maintain the NEGC

No.

Objective

Yr. 5 Definition of Success

Measurement of Success

1

Continue implementation of
core administrative supports to
the NEGC

NEGC is able to successfully pursue goals
and objectives and appropriately respond to
changing conditions.

NEGC 2011/2012
Workplan.

2

Budget Management

Operating expenses for the fiscal year are
within the budgeted amounts

Budget analysis of UNH
records

3

Continue close collaboration
with WG and AC

Work Group and Advisory Council
members feel supported in the work they
do and have access to the resources they
need to accomplish their goals. Meetings
and conference calls held

Work Group and Advisory
Council members feel
supported in the work they
do and have access to the
resources they need to
accomplish their goals.
Meeting and call minutes

4

Annual meeting

Meeting held

Meeting report

5

Communications and outreach
plan

Stakeholders report satisfaction with being
able to voice their opinions and feel that
they've been heard. Consistent increases in
NEGC web site utilization.

Stakeholder survey
responses, quarterly updates
sent, web site analytics

6

Implement Special Projects

Special Projects achieve stated goals within
agreed upon timelines.

NEGC 2010/2011
Workplan.

Quality Improvement

No.
1

Objective
Registry will be implemented
for all patients with
developmental delays at all 5

Yr. 5 Definition of Success
100% of appropriate data sheets entered at
each of the 5 sites;

Measurement of Success
# sheets entered/# eligible
patients by site;
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sites.

100% of data sheet 100% completed (i.e.,
no missing data elements)

# data sheets completed
correctly/# total sheets by
site;
Data sources are: 1) the
NEGC registry; and, 2) data
compilation for those sites
not yet on Registry.

2

Obtain exemption letters for
each site through CPHS

HIPAA BAAs in place at all participating
centers

NEGC offices have copies
of each HIPAA BAA.

3

Implement QI report structure

Standard report form in place and
functional.

The standard report
generated aggregate data for
all sites in Registry.

4

Submit for publication white
paper on process of quality
improvement in clinical
genetics services.

Paper completed

Paper completed and posted
on NEGC site.
Paper submitted and
published in Am J Med
Genet (Part C) in 2009.
White paper on the
Metabolic QI LC is in
process and will be
completed in year 5.
Abstract of the MET QI LC
to be submitted to annual
SIMD meeting late Fall
2011.

5

QI data submitted, analyzed
and reported from five clinical
genetics sites.

Registry reports all centers entering data in
Registry.
Data is complete for each site.

Registry reports total
numbers of records and data
entry points by site.
Registry reports on data
quality for completeness by
site
Five sites participating

6

Convene one “Breakthrough
Learning Series” in quality
improvement for NE
Metabolic Centers, based on
the Institute of Healthcare
Improvement using the
existing four sites and with the

Series completed.
Measures in place to assess implementation
of quality improvement activity in 8
metabolic centers
100% of participating centers will utilize care

a) X=participating centers;
Y=centers using checklists;
Y/X = % participating
centers active with checklists
b) # Children with MCAD,
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purpose of rapid dissemination
to other NE Centers. One
face-to-face meeting with 3
webinars will be completed.
We will target urban academic
or private clinical genetics
practices from Boston,
Worcester, Providence, New
Haven, etc.

checklists

PKU, = X;

100% of eligible patients will have completed
checklists by the end of Collaborative.

# Children with checklists
completed = Y

Information is complete for 90% of
patients identified and enrolled in the clinic
registry (by end of the collaborative).

Y/X= % of identified with a
checklist

100% checklist completion (number of
items on the checklist complete/total
number expected to be completed)

# Children with MCAD,
PKU, others conditions
identified and enrolled in
registry = X
Registry information
complete = Y
Y/X = % registry
information is complete
Score self on checklist for %
complete (e.g. 25%, 50%,
75%, 100%) X=number
complete; Y=total number;
X/Y=% complete.

Checklist activity leads to predicted and/or
unanticipated “tests of change” in the
practice.

# of predicted or not
predicted tests of change
(defined by site; require
PDSA cycle; # cycles) .

[“tests of change” are when an
improvement area is identified, an aim
written, and change ideas are tried out with
a few patients, refined, implemented and
measured (plan, do, study, act (PDSA)]
cycle.]
Optimal time interval between PKU screen
positive and PKU diagnostic confirmation.
Optimal time interval between MCAD
screen positive and diagnostic
confirmation.

# days from birth to
diagnosis (both PKU,
MCAD).
Same as above

Optimal time from confirmation of dx to
“metabolic control” of PKU.

# days from PKU dx to Phe
level < 6 mg/dL

Optimal time from MCAD diagnosis and

# days from MCAD
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patient diet counseling completed

diagnosis to all
diet/medication counseling
complete

Transition

No.

Objective

Yr. 5 Definition of Success

Measurement of Success

Continue to publish, present,
and disseminate transition
related agenda

Agenda promoted via published articles
and presentations

Publications, presentations,
and disseminated materials

Create materials for youth and
adults on metabolic disorders

Creation of Fact Sheets that list issues for
adults with these disorders written for a lay
audience. 4 fact sheets will be produced in
Year 5.

Distribution of Fact Sheets
through the internet and
clinics.

3

Continue to monitor new
advances in transition
programs – especially through
special education initiatives

Transition practices are summarized for
genetics and metabolism

Publication of review article
and/or posting of summary
to NEGC website.

Leadership training takes place.

Summary on training

4

Leadership training for teens
(Face Forward) with genetic
disorders in collaboration with
Children’s Hospital and Next
Step

Continued participation in QILC,
incorporation of transition elements into
QILC activities and recommendations.

Meeting reports

5

Participate in effort to improve
quality in metabolic clinics via
learning collaborative
methodology

6

Continue to represent
transition activities on LTFU
as needed.

Completion of study to determine validity
of the Uniform Assessment Method (using
PKU, UCD’s and Galactosemia as models)

Publication in a peer
reviewed journal

Seek out new opportunities and
collaboration

7

Collaborate with the National
Transition Resource Center
being developed at the Center
for Medical Home
Improvement

List of opportunities
identified and 'next steps' for
collaboration defined

1

2

Medical Home

No.

Objective

Yr. 5 Definition of Success

Measurement of Success
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1

Assessment of PCPs regarding
care provision for children
with complex conditions.

Survey implemented with response rate of
15%. Results reviewed and summary report
generated.

Evaluator review

Assessment of current
methods among genetic and
metabolic clinics regarding
communication and
coordination of care with
primary care physicians and
families.

Telephone interviews conducted with 75%
of clinic settings. Results reviewed and
summary report generated.

Evaluator review

2

Convene at least 3 meetings of
the MHWG during Year 5

Two conference calls and one face-to-face
meeting occur.

Meeting agenda and
attendees document the
meetings.

3

Continue to integrate meetings
and work with the Transition
Workgroup

Annual face-to-face meeting in November
2011 is a joint meeting of the two work
groups.

Meeting agenda and
attendees document the
meeting.

4

Assessment of PCPs regarding
care provision for children
with complex conditions.

Survey implemented with response rate of
15%. Results reviewed and summary report
generated.

Evaluator review

Dissemination, Education, and Marketing

No.
1

Objective

Yr.5 Definition of Success

Measurement of Success

Launch GEMSS website

Website launched

Evaluator review.

Continuously improve
GEMSS resource.

Expansion of modules utilized in GEMSS
for special educators. Targeted conditions
for Year 5 include: Down syndrome,
Williams syndrome, Achondroplasia and
other dwarfing conditions and possibly
NF1.

Meeting Minutes

Gather feedback and recommendations
from website visitors

Survey created,
implemented, results
analyzed, and followed up
on.

2

Disseminate GEMSS website

Increasing web hits throughout the year.

Google Analytics.

3

Improve utilization of genetic
education materials

Identification of new resources / tools to
be linked to the NEGC website and
distributed to stakeholders

NEGC Website, Weblogs,
Evaluator Review.

4

Collaborate with core staff to

Increased number of genetic services

Number of genetic services
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enhance 211 linkages for
genetic services

posted to each state's 211 system

posted to each state's 211
system

Effective Collaborations

No.

Objective

Yr. 5Definition of Success

Measurement of Success

1

Core staff and collaborative
council members participate in
national and regional groups

Each staff and CC member participate in at
least one regional or national work group

Work group rosters

2

Engage LEND students
and/or students at genetic
counseling programs in
research activities

Student participation results in poster or
abstract development

Product (poster/abstract)

3

Presentations/publications at
regional/national venues

Additional health care fields are educated
about the needs of individuals living with
genetic conditions. Presentations given /
publications issued

NEGC Publications /
Presentations list. # of
publications in medical
journals covering issues
facing genetic services,
cross-collaborative grants
submitted with primary care
providers.

Innovative Projects

No.

Objective

Yr. 5 Definition of Success

Measurement of Success

1

Quarterly reports from PI of
each project

Reports received

Quarterly and year end
reports

2

Release RFPs, select reviewers,
review applications, notify
applicants

Grants awarded

# of applications received, #
of applications funded

3

Present posters at annual
meeting

Posters created and displayed

# of posters displayed at
annual meeting

Ethical, Legal, and Social Issues

No.
1

Objective
Integrates ELSI issues within
projects

Yr. 5 Definition of Success
ELSI projects completed

Measurement of Success
Publications, activities
identified in Year End report

Long Term Follow Up

No.

Objective

Yr. 5 Definition of Success

Measurement of Success
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1

Document formal authority
for LTFU on state-by-state
basis.

Legislation, regulations or interpretations
of state rules

NBS coordinators

2

Develop State Agreements for
extending centralized database
to include LTFU variables

Contract amendments

Contracts in place

3

Data collection and analyses of
minimum data sets.

Updates on 70% of patients.

Summary data analysis

4

Refine dataset variables per
condition-specific needs

Variable list updated

Meeting Minutes

5

Participate in Interregional and
NCC activities

egular participation in activities.

Meeting Minutes,
presentations

Psychosocial Follow Up

No.

Objective

Yr. 5 Definition of Success

Measurement of Success

1

Validate method using
historical data to compare
results of the Uniform
Assessment System to
psychological testing results

Method identifies at least 90% of children
who are at risk for developmental delay,
learning disabilities, or emotional problems

Medical records at
Children’s Hospital Boston

2

Finalize method

Agreement is reached on a method

Members of work group

3

Develop computerized form

A system is up and running by 6 months
into the 5th year

A website

4

Pilot the method in 2
metabolic centers

Parents of 10 patients (from a range of
ages, 6 months to 10 years) will complete
the Uniform Assessment Method

Completed forms from 10
parents

5

Create a website for the
Uniform Assessment Battery

Includes description of the method,
instructions for completing questionnaires
and secure access to questionnaires and
results

Website

Quality Assurance

No.

Objective

Yr. 5 Definition of Success

Measurement of Success

1

Continued representation of
quality control workgroup in
regional and national forums

Participation at appropriate meetings

Documentation of
participation at meetings

2

Analyze applicability of lab-

Completion of the task as stated

Tables that accurately
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specific index categorizations
(developed over past 4 years)
to follow-up data of the
remaining disorders (those not
yet analyzed in first 4 years)
detectable by MSMS

represent the positive
predictive values of all
categories with all disorders

3

Analyze applicability of labspecific index categorizations
to follow-up data for those
new babies detected after
analyses for those disorders
which were done during earlier
phases of the study

Completion of the task as stated

Tables that accurately
represent the positive
predictive values of all
categories with all disorders

4

Hold regular conference calls
and face-to-face meetings, as
appropriate

Holding of said meetings

Documentation of meetings

5

Publish final findings in peerreviewed journal

Publication

Submission and publication

Evaluation

No.

Objective

Yr. 5 Definition of Success

Measurement of Success

1

Gather data on program
activities and outcomes and
provide ongoing feedback to
project staff on project
progress

Management staff report evaluation
support has been an effective aid in
decision making and program
improvement.

Annual review, Meeting
minutes of review.

2

Conduct annual stakeholder
survey

A majority of stakeholders participate in the
survey process and provide
recommendations for the project's
improvement

Data collected, More than
50% of known stakeholders
participate in the survey
(documented by Survey
Monkey), Stakeholder
Survey report generated and
published to website.

3

Complete annual reports
which can be used by staff to
improve project outcomes

Reports completed and utilized by staff to
improve project outcomes and utilized by
stakeholders to stay informed of project
progress.

Meeting minutes affirming
utilization of material,
Stakeholder Survey report
documenting majority
agreement that the report is
a useful resource for
stakeholders.
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4

Participate on national
outcome measurement efforts

NEGC is actively represented on national
measurement efforts.

Performance Measure
reports are fully completed
and delivered on time.

PROJECT CHALLENGES AND RECOMMENDATIONS
This section provides an overview of both project-wide and Workgroup level issues identified by Dr. Antal
along with recommended next steps. Challenges included in this section are drawn from issues raised by
stakeholders during the course of the project, findings from stakeholder surveys and annual meetings, and/or
staff review during project meetings. Status updates for each are defined as:
 Not addressed (0 of 12): no substantive activities have been undertaken
 In process (3 of 12): activities are under way to address the challenge but have not yet led to
substantive changes in practice
 Improving (8 of 12): activities have led to substantial improvements in the challenge area
 Addressed (1 of 12): the basic nature of the challenge has been successfully addressed by project staff
Since the previous year's report:
 one item (Implications of Insurance Reform) has been moved from 'new challenge' to 'in process.'
 one item (Access to Genetic Specialists) has been moved from 'not addressed' to 'in process'
 one item (Many Stakeholders, Limited Funds) has been moved from 'in process' to 'improving'

Update on Challenges Identified to Date
Status: In Process
Implications of Insurance Reform for Individuals with Genetic Conditions
Background: At several points during the last few years, several NEGC partners have noted the significant
challenges that are created by the lack of coverage for certain services by insurance policies. As health care
reform continues to be implemented, clarity will be needed as to the implications for the health and wellbeing of individuals living with genetic conditions. With greater clarity should come a better sense of what
actions can be taken to address some of the gaps in the health care system.
Recent Activity: Starting in Year 5, the NEGC took several steps to begin addressing this area. One, forming
partnerships with Kay Johnson (a national expert on MCH policy and funding challenges and a speaker in
health reform conversations) as well as the Catalyst Center (a national center dedicated to improving health
care coverage and financing for Children and Youth with Special Health Care Needs). Additionally, through
its innovative project, the NEGC is supporting the University of Connecticut Health Center's work to assess
implications of the Affordable Care Act for access to genetic medical services in New England. Lastly, the
NEGC has recently launched two new groups, the Advocacy group which has taken on this issue broadly, as
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well as a subgroup focused specifically on ensuring access to medical foods for families and individuals in the
region.
Recommendation: Review analysis work conducted by the University of Connecticut Health Center as well as
discussions and findings from the Advocacy and Medical Foods group. Consult with Kay Johnson and the
Catalyst Center to help the Advisory Committee and NEGC staff to identify best next steps.
Access to Genetic Specialists
Background: One of the challenges identified by the Medical Home workgroup during the first project year is
the scarcity of physicians with specialty training in genetics. More genetics doctors are leaving the field than
are entering it. Without other substantive changes in the field, this trend will threaten the NEGC goal of
improving patient access to quality care.
Recent Activity: The Medical Home workgroup has begun looking at this issue through an assessment of
communication lines between families, PCPs, and genetic specialists. The purpose of this work is to assess the
comfort level and communication preferences of primary care physicians related to caring for children with
rare conditions including genetic disorders. In combination with their survey work of genetic specialists, the
workgroup will have the potential to identify strategies for improving lines of communication, thus making
better use and enhanced dissemination of specialist knowledge across PCPs. Additionally, recent
developments in Year 5 have led to new partnerships with the NH LEND (Leadership Education in
Neurodevelopmental and Related Disabilities) program. The improved collaborations with both New
Hampshire's and Maine's activities in this area has the potential of maintaining and even improving PCP
access to specialists with genetic research knowledge and training.
Recommendation: Continue to support activities in these areas. Concerning the NH LEND partnerships,
outline a set of strategic goals that should be accomplished each year that meets the needs of both
organizations. Consider integration of recommendations developed by the Medical Home workgroup
concerning improvements in collaboration between PCPs, families, and specialists into the NH LEND
curriculum.
Availability of Care Management Information for Individuals with Genetic Disorders
Background: Another challenge for Medical Home practice is that little case management information for
genetic disorders has been published. If this information was more accessible, it is possible that PCPs could
perform more elements of patient care (and so help to address the lack of physicians trained in a genetic
specialty). During Years Two through Four, substantive efforts were made to educate both regional and
national level stakeholders about the need for a medical home.
Recent Activity: The care coordination and transition pilot projects helped to raise awareness of these issues
and created a set of online materials for use by a variety of stakeholders. The Long Term Follow Up
workgroup had major successes with the inclusion of Maine and Rhode Island as partners in tracking long
term follow up data. Lastly, the launching of the new Quality Improvement Learning Collaborative as resulted
in a long term learning partnership being formed across 8 metabolic centers in the New England region.
Recommendation:
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•

•

Continue supporting the Medical Home and Transition workgroup’s efforts to implement the care
planning and transition tools in a variety of settings. The NEGC should consider gathering a minimal
level of evaluation information (beyond web entries) to aid in future improvement and expansion of
the tools.
Continue supporting the QI and LTFU efforts to integrate data from a variety of settings so that an
accurate picture can be created on what does and does not produce successful outcomes among
individuals with a range of genetic and other health conditions. Re: LTFU, projects such as the
Hemoglobinapathy conference should be supported as they have great potential to bring together
LTFU data, leaders from across the nation, and area clinics to develop their thinking around best
practices and to set the stage for improvements in knowledge for gaining successful health outcomes.

Status: Improving
Many Stakeholders, Limited Funds
Background: Partners of the collaborative grappled with the challenge of multiple partners planning to submit
grant applications in response to the same RFA/PAs. Some of the issues encountered included: how to
balance sometimes competing interests, when the NEGC (and its fiscal agent, UNH) should take a leadership
vs. supporting role in a grant application, how to determine what is best for the region, and how partner
organizations can better balance working toward the NEGC mission while fulfilling their own organizational
mission. In August of 2009, the collaborative council met and, in the process of discussing the above issues,
developed a protocol for handling future grant opportunities. While the protocol is helpful for laying out a
process for initial discussion when an RFP notice is sent out, finding agreement to everyone’s satisfaction as
to which entity should lead may not always be achievable.
Recent Activity: The protocol has been used consistently over the past year to inform partners of emerging
grant opportunities, hold collaborative discussions around potential projects to pursue and to identify most
appropriate leads. During Year 4, the NEGC had considered applying for a grant to the Genetic Alliance to
integrate Family Health History Patient Education Toolkits into a health care setting.. Based on discussion
with partners from Vermont, it was determined that it was most appropriate for a community health center in
that state to take the lead on applying for the initiative. However, this group ultimately decided not to apply.
A review of how this process worked during the past year indicated that this was the most feasible solution.
Recommendation: Continue to seek out and take advantage of opportunities to collaboratively improve grant
resources in the region. Review annually with partners the NEGC's approach to this area to determine how
well it is working and to identify any recommendations for improvement in the process.
Lack of Specialty Care Providers for Adults
Background: During Year One, concerns were raised about the ability for youth with genetic conditions who
were transitioning to adult care to have regular access to a PCP in their adult life.
Recent Activity: The Transition Workgroup, at both a national and regional level, has continued to support
access to continuous care among youth. This includes dissemination of the Transition toolkit, leading national
and regional dialog on Transition, and partnering with the Face Forward program to implement youth
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directed programs geared towards giving youth the skills sets they need to manage a successful health care
transition.
Recommendation: Efforts in this area should continue to be supported to ensure that as many youth as
possible find a seamless transition in their care provision from youth to adult health care systems. Parallel to
this, it may be helpful to conduct a region wide survey every few years to gain an accurate scope of the
problem (e.g. % of youth ages 19-29 with genetic conditions without access to a PCP) as well as a better
understanding of the primary barriers for effective care among the members of this group.
Common Conceptions of People, Roles, and Decision Making Processes
Background: During Years Two and Three, substantive efforts were made to revise the NEGC website with
information on project structure, major events and membership, increase email communications and updates,
provide more accessible meetings, as well as organize monthly calls with workgroup chairs. Despite these
endeavors (and some improvement since then), results from the Stakeholder Survey and the NEGC annual
2009 meeting continue to indicate a need for better dissemination of information around the work of the
NEGC and the roles of each of the workgroups and projects.
Recent Activity: In Year Four, the NEGC launched a major redesign of its website to make information more
accessible and regularly implemented quarterly email updates to partners in order to inform them of major
activities of the NEGC. Additionally, the NEGC focused outreach efforts to genetic counselors as well as
advocates and family members (through the creation of a new Advocacy Committee).
Recommendation: As documented by respondents to the participant survey, efforts to communicate the
NEGC's mission to stakeholders has resulted in improvements in understanding. It is recommended that the
NEGC continue efforts to update the website on a regular basis, inform partners of evolving national
priorities, continue with the provision of quarterly updates via email, and facilitating communication at the
annual meeting. In preparation for any future annual meetings, it would be helpful to allocate 15 to 30 min to
briefly highlight the year's accomplishments to all meeting participants to better ensure that everyone is on the
same page in moving forward
Cross-Fertilization of Ideas, Resources
Background: Findings from the 2009 annual meeting as well as several individuals from the stakeholder
survey noted the continued need to reach out to like-minded groups at the national, regional, and state levels.
During Year Three, new partnerships were formed with the Birth Defects Consortium, Genetic Alliance, and
area hospitals. As the NEGC continues to grow and promote the health and social well-being of those with
inherited conditions through collaborations of its partners, it will be critical to sustain existing partnerships
and identify new ones.
Recent Activity: Additional outreach during Year Four focused on the Birth Defects Consortium, genetic
counselors, and advocates. Notably, concerted efforts were made to begin strategic integration of NEGC and
NH LEND activities.
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Recommendation: Continue to use the opportunity of the annual meeting, with its range of participants, to
both review current partnerships and identify needed new ones. Further solidify partnership arrangements
with NH LEND, and pursue potential partnership ideas identified in the 2011 NEGC Stakeholder survey.
Geographic Barriers to Meeting
Background: Continued limitations in use of state funds for travel, as well as multiple national and regional
meetings pose substantive challenges to holding collaborative meetings. During Years Three and Four, the
NEGC has increased its use of Webex technology for meetings and has sought to combine meeting events
with other initiatives whenever possible (e.g. combination of NERGG and NEGC annual meeting).
Recent Activity: Workgroup leaders continue to make good use of conference calls and technology to support
their meetings when face to face meetings are not feasible. These resources continue to provide an effective
means for members to conduct their work.
Recommendation: Explore more dedicated spaces and/or equipment among partners to further improve
web-based (e.g. Webex or similar) technologies. While Webex has been useful in the past, video and audio
capabilities are sometimes limited for full group meetings and can limit potential participation.
Quality Data Systems
The QI, Transition, Medical Home, and LTFU Workgroups have all expressed a need for quality patient data
systems to inform their work and improve outcomes for individuals with genetic conditions. During Year
Three, substantive progress was made in laying the foundation for data improvement. This was achieved
through work by the LTFU Workgroup in Maine supporting integration of LTFU systems, QI initiatives to
start a learning collaborative, and Medical Home and Transition Workgroup efforts to improve on
information collected (and how it was used) between patients, PCPs, and specialists.
Recent Activity: In Year Four, substantive progress was made through the addition of Rhode Island to the
LTFU partnership, establishment of BAAs with Maine (Vermont is pending) and Dartmouth clinics to track
data on children with developmental delay, and the launching of the quality improvement learning
collaborative which will look at quality improvement initiatives for PKU and MCAD.
Recommendation: As data collection activities get more fully underway and used for quality improvement
work, there will be a natural collective interest in sharing findings with broader audiences to ensure broad
dissemination of useful findings. Given the distinction that IRBs can place on research for the sake of
evaluation, quality improvement, vs. improving knowledge, it will be important to clarify what the potential
implications are for IRB reviews and the most appropriate role for each group to take concerning the
handling and use of protected health information for vulnerable populations.
Patient Access to Genetics Information.
Background: Concerns have been raised during the course of the project relative to the ability for patients
with a genetic condition to access relevant information. During Years Two through Four of the project,
substantive additions were made to the NEGC website to help fill this gap. Additionally, the DEM
workgroup began reviewing resources for appropriateness and potential inclusion on the website.
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Recent Activity: During Year Four, the NEGC launched a new Advocacy workgroup which has established
access to care and understanding implications of the Affordable Care Act as one of its primary areas of focus.
In addition, this group will serve as a reviewer of the NEGC website and provide suggestions concerning
additional material to include that would benefit patients and their families.
Recommendation: Continue supports for the Advocacy workgroup and the new Medical Foods sub group
that begins in Year Five. Additionally, make resources available to complete NEGC efforts to support the 211
system in New England. Currently, there is a substantive lack of information on genetic services in this
system. It would be helpful to request relevant service providers to link their information in to this system in
order for individuals and families to have an additional route of access to critical care and support
information.
Tracking Progress of Work Groups
Background: In Year One, an issue was raised by evaluation staff concerning the flow of information and
timeliness of material / feedback provided. There have been continued improvements in communication as
observed via monthly meetings, more timely responses to federal report requests, and openness in discussion
during collaborative council meetings. The addition of an objective and activity tracking plan in Year Three
aided oversight and planning of project activities substantially.
Recent Activity: Monthly chair calls, posting of workgroup minutes to the website, and regular use of the
NEGC workplan have kept staff well informed of the progress of the NEGC and helped to identify needed
areas for action.
Recommendation: To support efforts in this area, it would be helpful to establish a standard set of items to
include in workgroup minutes. At a minimum, it is recommended that all workgroups should include the
following information in tracking their meetings: meeting date, participants, major discussion points, barriers
encountered and solutions identified (if any), next steps and person(s) responsible. Though not always
possible (given the need for formal approval of minutes), minutes should be posted on the NEGC website
within two weeks following a meeting.
Status: Addressed
Development of Logic Models and Performance Measures for Workgroups
During Year One, evaluation staff sought to develop a series of additional logic models and measures with
each of the Workgroups. However, given the status of the project and the need for chairs to focus on the
start up of the program it was decided by both project management and evaluation staff that such reporting
went beyond the immediate needs of the project. While information flow improved in Year Two, workgroup
chairs agreed to an initial set of performance measures for their activities during Years Three and Four. These
measures were then tied to goals, objectives, and individual activities and used throughout the course of the
year for program oversight. While there will continue to be refinement of the process in the years ahead, the
necessary infrastructure and culture is in place that will enable effective use of the work carried out by the
NEGC.
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APPENDIX A: NEGC ORGANIZATIONAL CHART

NEW ENGLAND REGIONAL COLLABORATIVE ORGANIZATIONAL CHART
NEW ENGLAND REGIONAL COLLABORATIVE ADVISORY COMMITTEE
NH

MA

RI

CT

ME

VT

REPRESENTATIVES FROM:
Public Health

Genetics Services

Consumer Organizations

REGIONAL COORDINATING CENTER (RCC AT UNH
MANAGEMENT TEAM
•John Moeschler, MD, Co-PI
•Monica McClain, PhD, Co-PI, Project Manager
•Karen Smith, Project Coordinator
•Peter Antal, PhD, Project Evaluator

SPECIAL PROJECTS
•Workforce
•Advocacy and Education
•Emergency Preparedness
• Innovative Grants

COLLABORATIVE COUNCIL WORKGROUP/LEADERS
ACCESS TO SERVICES
DISSEMINATION,
EDUCATION,
MARKETING
Leah Burke, MD

CT

LINKAGES TO MEDICAL
HOME
Carl Cooley, MD

RI

TRANSITION TO
ADULT SERVICES
Susan Waisbren, PhD

QUALITY
IMPROVEMENT
John Moeschler, MD

STATE REPRESENTATION
MA
NH

FOLLOW-UP
Anne Comeau, PhD

ME

LABORATORY QUALITY
ASSURANCE
Roger Eaton, PhD

VT

APPENDIX B: NEGC Grant Applications
Direct Applications
Grant Name

Description

Amount

Natural History of Disorders
Identifiable by NBS

Project Yr 4. NIH. Collaborate
with NYMAC to assess natural
history of several targeted
conditions in order to create a
stronger foundation for improving
care.

NOT FUNDED

Administrative Supplemental

Project Yr 3. HRSA; funds for
legal analysis work and creation of
the learning collaborative.

$45,000 FUNDED

Administrative Supplemental

Project Yr 2. HRSA; funds for QI
data registry and electronic
medical record pilot

June 2010
$75,000 FUNDED
April 09

Assess capacity of genetic
workforce

Project Yr 2. ACMG; assess
genetic workforce in light of
expanded nbs; Bob McGrath will
collaborate

$36,000 FUNDED

Down Syndrome Surveillance

Project Yr 2. CDC; 4 yr grant for
$400,000 to study prevalence of
DS at birth and older ages;
overview of health across lifespan;
Bob McGrath, David LaFlamme,
IOD will collaborate

NOT FUNDED

Genetics Health Care Quality
Improvement Project: A MultiState Pilot Collaboration

Project Yr 2. AHRQ; $300,000 for
2 yrs

NOT FUNDED

Dartmouth Translational Research
Center

Project Yr 2. Submitted by John
Moeschler to supplement QI
project

April 09

QI activities
NOT FUNDED

Galactosemia and Premature
Ovarian Insufficiency

Project Yr 2. AUCD;
collaboration with Susan
Waisbren; submitted Oct 08

NOT FUNDED

Letters of Support for Partner Applications
Grant Name

Description

Amount

Genetics in Primary Care Institute

Project Yr 4. American Academy
of Pediatrics. Create a community
of learners to enhance primary
care provider ability to provide
genetic related services, address
systems and policy supports to
accelerate provision of genetic
medicine, assess residency training
curriculum for genetic medicine.

Funded.

Family to Family Health
Information Center

Project Year 4. Federation for
Children with Special Needs.

Funded.

NBSTRN

Project Year 4. American College
of Medical Genetics. Build an
electronic data capture tool for
long term follow up of children
identified by newborn screening.

Letter written supporting need for
activity.

Noonan Foundation

Project Year 4. Children’s Hospital Not funded.
Boston. For follow up meetings of
the Face Forward Program.

The Parent-Child Relationship and
Newborn Screening: Preserving
the Ties that Bind

Project Year 4. Assess whether the
parent-child relationship is
disrupted in parents whose infant
receives an initial out-of-range
newborn metabolic screening
result and whether uncertainty
surrounding the result is
associated with reduced selfreported ratings of bonding for
both mothers and fathers.

Not funded.

Clearinghouse of NBS
Information

Project Yr 3. The NEGC
supported an application by the
Genetic Alliance and NNSGRC.

Funded. The NEGC received a
subcontract of $10,000 per year to
support further collaboration.
Leah Burke serves on the project
Advisory Committee

Congenital Conditions Program

Project Yr 3. The NEGC
supported an application by the
Genetic Alliance and Family
Voices.

Funded to Genetic Alliance.

APPENDIX C: NEGC PRESENTATIONS LIST
* New in Year Four
Sharing Work on Project Activities
* Region 1 Quality Control Project: Multicenter
Validation of Algorithms to Improve Communications of
Positive Newborn Screening Results to the Medical Home.
Secretary’s Advisory Committee on Heritable
Disorders in Newborns and Children, Laboratory
Standards and Procedures Subcommittee Meeting,
May 2011, Washington, D.C.
Sahai I, Caggana M, Morrissey M, Rodriguez D,
Baker, M, Hoffman G, Sommers P, Manning A,
Eaton R.
* Joint presentation by five Regional Genetics
Collaboratives
Association of Maternal and Child Health
Programs, Washington DC
February 2011
Karen Smith
* LTFU data on children diagnosed with long-chain
hydroxyacyl-CoA dehydrogenase deficiency (LCHAD) by
NBS. December, 2010, Portsmouth NH.
Dr. Inderneel Sahai
* Presentation of Massachusetts data as a part of the CF
NBS and Care Quality Improvement Short Course. 2010
24th Annual North American Cystic Fibrosis
Conference. October 21-23, 2010. Baltimore, MD.
Dr. Anne Comeau
* A guide for the classroom for children with genetic
conditions: preliminary needs assessment and development.
National Coalition for Health Professional
Education in Genetics Annual Meeting, Sept. 2324, 2010; Bethesda, MD.
Dr. Leah Burke
Update on LTFU activities in New England.
NCC/RC PU Annual Meeting,
November 17, 2009, Bethesda, MD.
Dr. Anne Comeau

Poster session:
•
NEGC
•
NEGC Work Groups
•
Innovative Projects
NEGC Annual Meeting
Dec 2009
Meet Your Neighbor: NEGC
Genetic Alliance webinar
May 2009
Amy Schwartz
Poster Session: NEGC
ACMG Meeting, Tampa, FL
March 2009
John Moeschler
Poster session: NEGC
NCC/RC Meeting, Bethesda, MD
January 2009
John Moeschler & Amy Schwartz
Poster session:
•
NEGC
•
NEGC Work Groups
•
Innovative Projects
•
CSHN Survey Analysis Presentation – Bob
McGrath
NEGC Annual Meeting
Dec 2008
Long Term Follow up of Newborn Screening Conditions in
New England ~ New Hampshire NBS Advisory
Committee
October 2008
Anne Comeau
Long Term Follow up of Newborn Screening Conditions in
New England ~ Rhode Island NBS Advisory
Committee
September 2008
Anne Comeau

Long Term Follow up of Newborn Screening Conditions in
New England ~ Maine NBS Advisory Committee
September 2008
Anne Comeau
Educating Students
Public Health and Genetics
Rivier College and Nursing School, Nashua, NH
March 2009
Amy Schwartz
Class at UNH Graduate Program: Fundamentals of
Public Health
Fall 2008
Amy Schwartz (co-faculty)
Innovative Project: Patients as Teachers
Multiple presentations to medical school students
2007-2009 (2 funding cycles)
Mark Korson, Tufts University, project PI
Innovative Project: Nurse Educators Incorporate ANA
Guidelines on Genetics
Videotaped training module presentations, now
available online
2007-2008
Susan Capasso, St. Vincent’s Academy, project PI
Training Professionals
* Parents’ role in specialty referrals: views from both sides of
the exam table. Pediatric Academic Societies Annual
Meeting, April 28-May 1, 2011, Denver, CO.
Fischer SH, Cooley WC, Mazor KM, Dworetzky
B, Stille CJ.
* Poster Session: Parents’ role in specialty referrals: views
from both sides of the exam table.
Pediatric Academic Societies Annual Meeting,
April 28-May 1, 2011, Denver, CO.
Fischer SH, Cooley WC, Mazor KM, Dworetzky
B, Stille CJ.
* Poster Session: Notes from the front lines: psychosocial
follow-up of newborn screening.
ELSI Congress: Exploring the ELSI Universe,
April 12-14, 2011, Chapel Hill, NC.

Fanos JH.
* Neurocognitive Outcomes in PKU.
South East Regional Genetics Group (SERGG),
March 31, 2011
New Orleans, LA (presented via webinar)
Waisbren, S.
* Poster Session: The adult galactosemic phenotype.
Society for Inherited Metabolic Disorders Annual
Meeting, Feb 27-March 2, 2011; Pacific Grove,
CA.
Waisbren S.
* “Surviving to Thriving: Improving Long-term Outcomes
in Sickle Cell Disease.” New England Conference
sponsored by the Hemoglobin Workgroup.
September 16 2010, Boston, MA.
* Poster Session: A guide for the classroom for children with
genetic conditions: preliminary needs assessment and
development.
National Coalition for Health Professional
Education in Genetics Annual Meeting, Sept. 2324, 2010; Bethesda, MD.
Burke L.
CF: recommendations to increase Newborn Screening
efficiency.
7th International Congress, Latin American
Society of Inborn Errors of Metabolism and
Neonatal Screening,
December 7, 2009, Cancun, Mexico
Anne Comeau
Neurocognitive issues in PKU and Transition to Adult
Care
National PKU Alliance Mtg
Texas
January, 2010
Susan Waisbren
Implementing AAP Developmental Screening Guidelines
in the Primary Care Medical Home
NH Pediatric Society
April 2009
Carl Cooley

DEM work group project: Family Health History
Awareness
Multiple presentations during pilot phase to health
care community in NE, now available online
2007-2009
Meagan Krasner
Incorporating Genetics Into the Medical Home
NEGC/NERGG Collaborative Session at annual
meeting
December 2008
Carl Cooley
Genetics presentation at NERGG annual meeting
December 2008
Leah Burke
The Primary Care Medical Home and the Care of
Children with Metabolic Disorders
New England Metabolic Program Consortium
November 2008
Carl Cooley
Newborn Screening Molecular Training Workshop
November 18-24, 2008
Anne Comeau
Newborn Screening and Genetic Testing Symposium
November 3-6, 2008
Anne Comeau
Genetic Health Care Quality Improvement.
Annual Meeting of the National Newborn Screening
and Genetics Coordinating Center, Bethesda MD.
January 7, 2009.
John Moeschler
Development of Collaborative Organizations.
National Coordinating Center of the Newborn
Screening and Genetics Collaborative meeting.
Chicago, IL.
June 5, 2009.
John Moeschler
Lectures given: Office-Based Evaluation of Children with
Suspected Genetic or Metabolic Disorders.
American Academy of Pediatrics Visiting Professor to
the Georgia Academy of Pediatrics. The Diagnostic
Evaluation of Children with Autism & Related
Diagnoses.

Amelia Island, FL. Host Paul Fernhoff, M.D. and
Frank Bawyer, M.D., FAAP.
June 18-19, 2009.
John Moeschler
Translating clinical guidelines into quality improvement: the New
England Genetics Cooperative experience.
American College of Medical Genetics, Annual
Meeting. Quality Improvement Special Interest Group.
Marc Williams, M.D., host. Albuquerque, N.M.
March 24, 2010.
John Moeschler
Workshop: Genotype-first or phenotype-first? How to balance
laboratory testing with genetic evaluations. Plenary Presentation:
“Clinical evaluation of patients with developmental delays, birth
defects and other potential genetic disorders—why complete
evaluation should precede genetic testing.
American College of Medical Genetics, Annual
Meeting. Ballroom C, Albuquerque Convention Center.
Robert Saal MD and Yves Lacassie MD, hosts.
March 25, 2010.
John Moeschler
Keynote address
International Conference for Adults and Children
with PKU, Chicago, IL
Aug 2008
Susan Waisbren
Transition: Psychosocial Considerations
(power point presentation, available on NEGC
website)
Susan Waisbren
Innovative Project: Sickle Cell Disease Life Skills
Training to Improve Outcomes
Multiple presentations to young adults in NE
2007-2009
Bill Kubicek, Next Step, project PI
Communication of relative risk for cystic fibrosis following a
positive newborn screening result. Newborn Screening
and Genetic Testing Symposium, November 3-6,
2008, San Antonio, TX
Hale JE, Parad RB, Dorkin HL, Gerstle r, Lapey A
O’Sullivan BP, Spencer, T, Yee W and Comeau
AM.

Quality measures enhanced by short and long-term follow up
in a newborn screening program collaborating with multiple
centers.
University of Massachusetts Medical
School/Commonwealth Medicine Conference,
October 25, 2007, Worcester, MA.
Hale JE, Parad RB, O’Sullivan BP, Quizon AI,
Martin T, Yee W, Dorkin HL, Comeau AM.

Quality measures enhanced by short and long-term follow up
in a newborn screening program collaborating with multiple
centers.
21st Annual North American CF Conference
October 3-5, 2007, Anaheim, CA.
Hale JE, Parad RB, O’Sullivan BP, Quizon AI,
Martin T, Yee W, Dorkin HL, Comeau AM.

APPENDIX D: NEGC PUBLICATIONS LIST
* New in Year Four
Peer-Reviewed Journal Articles

1. * McGrath RJ, Stransky ML, Cooley WC, Moeschler JB. National profile of children with Down
Syndrome: disease burden, access to care, and family impact. J Pediatr. 2011; in press.
2. * Woo HC, Lizarda A, Tucker R, Mitchell ML, Vohr B, Oh W, Phornphutkul C. Congenital
hypothyroidism with a delayed thyroid-stimulating hormone elevation in very premature infants:
incidence and growth and developmental outcomes. J Pediatr. 2011;158(4):538-42.
3. * Sahai I, Eaton RB, Hale JE, Mulcahy EA, Comeau AM. Long-term follow-up to ensure quality care
of individuals diagnosed with newborn screening conditions: early experience in New England. Genet
Med. 2010;12(12 Suppl):S220-7.
4. * Hale JE, Parad RB, Dorkin HL, et al. Cystic fibrosis newborn screening: using experience to
optimize the screening algorithm. J Inherit Metab Dis. 2010;33(Suppl 2):S255-61.
5. Waisbren, S. Establishing a consortium for the Study of Rare Diseases: The Urea Cycle Disorders
Consortium. Mol Genet Metab., Feb 2010; 100 (Suppl 1): S97-S105
6. White DA, Waisbren S, van Spronsen FJ. The psychology and neuropathology of phenylketonuria.
Mol Genet Metab. 2010;99(Suppl 1):S1-2.
7. White DA, Waisbren S, van Spronsen FJ. Final commentary: a new chapter. Mol Genet Metab.
2010;99(Suppl 1):S106-107.
8. Waisbren S, White DA. Screening for cognitive and social-emotional problems in individuals with
PKU: tools for use in the metabolic clinic. Mol Genet Metab. 2010;99(Suppl 1):S96-99.
9. Koch R, Trefz F, Waisbren S. Psychosocial issues and outcomes in maternal PKU. Mol Genet Metab.
2010;99(Suppl 1):S68-74.
10. Brumm VL, Bilder D, Waisbren SE. Psychiatric symptoms and disorders in phenylketonuria. Mol
Genet Metab. 2010;99(Suppl 1):S59-63.
11. Moeschler JB, Amato RS, Brewster T, et al. Improving genetic health care: a Northern New England
pilot project addressing the genetic evaluation of the child with developmental delays or intellectual
disability. Am J Med Genet C Semin Med Genet. Aug 15 2009;151C(3):241-254.
12. McGrath RJ, Laflamme DJ, Schwartz AP, Stransky M, Moeschler JB. Access to genetic counseling
for children with autism, Down syndrome, and intellectual disabilities. Pediatrics. Dec
2009;124(Suppl 4):S443-449.
13. Homer CJ, Cooley WC, Strickland B. Medical home 2009: what it is, where we were, and where we
are today. Pediatr Ann. Sep 2009;38(9):483-490.
14. Cooley WC, McAllister JW, Sherrieb K, Kuhlthau K. Improved outcomes associated with medical
home implementation in pediatric primary care. Pediatrics. Jul 2009;124(1):358-364.

15. Waisbren SE, Levy HL, Noble M, et al. Short-chain acyl-CoA dehydrogenase (SCAD) deficiency: an
examination of the medical and neurodevelopmental characteristics of 14 cases identified through
newborn screening or clinical symptoms. Mol Genet Metab. Sep-Oct 2008;95(1-2):39-45.
16. Waisbren SE. Expanded newborn screening: information and resources for the family physician. Am
Fam Physician. Apr 1 2008;77(7):987-994.
17. Prosser LA, Ladapo JA, Rusinak D, Waisbren SE. Parental tolerance of false-positive newborn
screening results. Arch Pediatr Adolesc Med. Sep 2008;162(9):870-876.
18. Hsu HW, Zytkovicz TH, Comeau AM, et al. Spectrum of medium-chain acyl-CoA dehydrogenase
deficiency detected by newborn screening. Pediatrics. May 2008;121(5):e1108-1114.
19. Anastasoaie V, Kurzius L, Forbes P, Waisbren S. Stability of blood phenylalanine levels and IQ in
children with phenylketonuria. Mol Genet Metab. Sep-Oct 2008;95(1-2):17-20.
Chapters
* Fanos JH, Wiener L, Brennan T. Potential impact of genomic information on childhood sibling
relationships. In: Handbook of genomics and the family, Issues in clinical child psychology, K.P.
Tercyak (ed.), Springer Science, 141-61,2010.

APPENDIX E. SUMMARY OF WORKGROUP MILESTONES YEAR 4

June 10

July 10

Innovative
Projects

Proposals
due for
2010-2011
projects.
Review
process
completed
&
awardees
notified;
CFN
grants
made
available

2010-2011
Project
start date

Advisory
Committee

Part in
review
process for
inno.
Projects.

Project Staff

Aug 10

Sept 10

Oct 10
Legal
analysis
completed
of state
approaches
to PHI
utilization

Nov 10

Dec 10
Annual
NEGC
Meeting.
NEGC
website
launched.
Redesigned
logo.

Jan 11
NEGC
Newsletter
launched.

Feb 11
.

Special
Advisory
Mtg to
revise
policies (90
– 60)

Annual
Meeting
held.

Meeting
to review
Innovative
Projects

Mar 11
Reapp. for
federal
funding

April 11
Emerg.
Prepared.
Conf.

May 11
Launch of
Advocacy
Committee

LOI due
for 20112012 apps

2010-2011
projects
end

Began
planning
with
reapplicati
on in mind

Collab.
Council

Yr 3
Stakeholde
r Survey
complete

Evaluation

Quality
Improve.

Medical
Home

National
measures
submitted.
Yr 3
Stakeholde
r Survey
results
released

BAA
signed with
Dartmouth.

Year 4
Annual
Mtg. report
released.

BAA
signed with
Maine.

Joint
meeting of
the
Medical
Home and
Transition
groups.

Survey of
primary
care
providers

Joint
meeting of
the MH
TR groups,
Survey
completed,
Presentatio
n of pilot
care tool at
Pediatric
Acad.
Societies
meeting

Teen
Challenge
– Boston,
9 youth

Transition

Diss.
Education &
Marketing

Focus
group
report
completed

NCC
Collab.
special ed
project
article

Joint
meeting of
the
Medical
Home and
Transition
groups.

Poster
present at
NCHPEG

First Draft
version of
online
educator’s
resource

Report on
usage of
toolkits
Review
and
feedback
NEGC
website

Formalizati
on of
content
developme
nt for
GEMSS

Meetings
with
Silvertech
to design
website

SilverTech
completes
website
which is
now ready
for content
Chair
facilitates
Emer Prep
meeting
with other
labs in
attendance

Lab QA

Long-Term
Follow-up*

Joint meeting of
the Medical Home
and Transition
groups. 5 new
members

Hemoglobi
napathy
conference
on best
practices

Presented
LTFU data
to 24th
Annual CF
Conf.

Presented
LTFU data
on
LCHAD at
NEGC
Annual
Mtg.

Contract
signed with
Rhode
Island to
participate
in LTFU.

Present to
SACHDN
C

APPENDIX F. WORKGROUP MEETINGS YEAR 4

Management

June
10

July
10

Mtg

Mtg

(4)

Aug
10

Sept 10
Mtg

(2)

(3)

Oct
10
Mtg
(4)

Nov 10
Mtg
(2)

Advisory
Committee
Collaborative
Council

Mtg
(2)

Mtg
(4)

Mtg

Mtg

Mtg

Mtg

Mtg

Mtg

Feb 11

Mar
11

April
11

May
11

Mtg

Mtg
(3)

Mtg
(1)

Mtg (3)
(3)
Mtg

Mtg
(annual)

Mtg

Quality
Improvement
Learning
Collaborative
(QILC)

Dec 10

Jan
11

Mtg

Mtg
(annual)

Mtg

Mtg

Medical Home

Mtg

Mtg

Mtg

Mtg

Mtg

Mtg

Lab QA
Dissemination,
Education, &
Marketing

Mtg

Transition:
Regional

Mtg

Transition:
National

Mtg

Mtg

Mtg

Mtg

Mtg

Mtg

Mtg

Mtg

Mtg

Mtg

Mtg

Mtg

Mtg

Mtg

Mtg

Mtg

Mtg

Mtg

Mtg

Mtg

Mtg

Transition &
Medical Home

Mtg

Long-Term
Follow-Up: Full

Mtg

Mtg

Mtg

Mtg

LTFU: Metabolic
Workgroup
LTFU: Hgb

Mtg

Mtg

Mtg

University of New Hampshire, Institute on Disability

New England Genetics Collaborative

Workgroup
LTFU: CF
Workgroup

Mtg

